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 Chemically Modified Proteins as Functional Biomaterials 
 
Vindya Kalani Thilakarathne, PhD 
University of Connecticut, 2013 
 
                      The goal of this thesis was to explore how to improve the functionality of 
proteins as biomaterials by chemical modification of the surface of the protein. In order 
to achieve this goal protein surfaces were decorated with small amine molecules and 
large synthetic polymers. The introduced functionality by the facile modification, 
allowed the protein to behave as a successful biocatalysts, biosensor and a useful 
scaffolding platform.  
                  Thorough characterization was performed using various biochemical, 
bioanalytical biophysical methods to evaluate the structural integrity, enzymatic activity 
, thermodynamic and kinetic stability of chemically modified proteins/enzymes. 
Improved stability and reversible thermal denaturation were key stand out properties 
observed with chemical modification. 
                   The study was further expanded to understand the effect of modification for 
the interaction between chemically modified protein and macromolecules. As a model 
system triethylenetetramine modified hemoglobin and polyacrylic acid were used to 
investigate the charge dependency on thermodynamics of  protein/polymer interaction. 
A collaborative research project between Kasi and Kumar groups exploit the 
protein/polymer interaction towards a development of biosensor to detect small 
molecules. 
                   Vindya Kalani Thilakarathne - University of Connecticut, 2013  
       
          Furthermore we studied the chemically modified bovine serum albumin (BSA) as 
a scaffolding platform for construction of protein and DNA based artificial antenna 
complex to capture solar energy. Chemical modification allows BSA to reverse its 
negative charge and facilitate the binding to DNA. Donors and acceptor chromophores 
were loaded in DNA/BSA scaffold and functioned as an efficient and stable antenna 
complex.  Thus, functionalities introduced to the protein by chemical modification have 
shown a major influence towards the application of proteins as successful functional 
biomaterials. 
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NH4Cl and TETA  (lanes 2, 3 and 4, respectively, 40 mM Tris acetate, gel has been run 
at pH 6,) and samples were loaded into wells at the middle of the gel (dotted line). 
Figure 1.2 A. Agarose gel of unmodified carbonic anhydrase  (lane 1), and modified 
CA,  (lanes 2, 3, 4) synthesized with L-lysine, TETA and NH4Cl, respectively according 
to the conditions listed in Table 1. (running buffer, 40 mM Tris acetate, pH 8). B. 
Agarose gel of unmodified hemoglobin (lane 1), and modified hemoglobin,  (lanes 2, 3, 
4) synthesized with TETA, L-lysine and NH4Cl respectively according to the conditions 
listed in Table 1. (running buffer, 40 mM Tris acetate, pH 8). 
Figure 1.3 A. Agarose gels of modified GO (lane 1) and GO modified by reaction with 
with L-lysine, NH4Cl and TETA  (lanes 2, 3 and 4, respectively, 40 mM Tris acetate, 
gels were run at specific pHs, as indicated).   B. Agarose gels of modified carbonic 
anhydrase in 40 mM Tris acetate at room temperature. In each gel, lane 1 contained to 
unmodified carbonic anhydrase, lane 2 is carbonic anhydrase modified with 20 mM 
TETA and lanes 3 and 4 were carbonic anhydrase modified with 200 mM L-lysine and 
200 mM NH4Cl, respectively. C. Agarose gels of modified hemoglobin in 40 mM Tris 
acetate at room temperature. In each gel, lane 1 contained unmodified hemoglobin, lane 
2 is hemoglobin has been modified with 20 mM TETA at pH 5 and lanes 3 and 4 were 
hemoglobin modified with 200 mM lysine (pH 5) and 200 mM NH4Cl (pH 5), 
respectively. When pI of the protein equals to the pH of the running buffer, protein does 
not move out of the well, which are located in the middle of the gel. 
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Figure 1.4. Agarose gels of GO (lane 1) , GO-Lysine  (lane 2) , GO-NH4Cl  (lane 3) and 
GO-TETA (lane 4) in 40 mM Tris acetate, gels were run at specific pHs, as 
indicated.When pI of the protein equals to the pH of the running buffer, protein does not 
move out of the well, which are located in the middle of the gel. Mid point of each 
protein band as indicated was taken as the distance migrated in the agarose gel. Distance 
and charge relationship of the modified GO derivatives, relative to the distance and 
charge of unmodified GO, were estimated using imageJ 1.46r software from NIH and 
average charge at pH 7 was tabulated in Table 1.2. 
Figure 1.5. Plot of pH vs charge of (A) GO,  (B) GO-Lysine, (C) GO-NH4Cl and (D) 
GO-TETA. The Y-intercept of each is the corresponding isoelectric point (pI). 
Figure 1.6. SDS PAGE of A. the modified glucose oxidase. Lane, 1 is the molecular 
weight marker and lane 2 is unmodified glucose oxidase. Lanes 3 to 6 are glucose 
oxidase samples modified with TETA, PEI, NH4Cl and L-lysine, respectively.   The 
extent of crosslinking in each of these lanes is indicated under the gel; B. modified 
hemoglobin, Lane 1 is the molecular weight marker and lane 2 is unmodified 
hemoglobin. Lanes 3 to 5 are modified carbonic anhydrase, synthesized using L-lysine, 
TETA and NH4Cl, respectively; C. modified carbonic anhydrase, Lane 1 is the 
molecular weight marker and lane 2 is unmodified carbonic anhydrase. Lanes 3 to 5 are 
modified carbonic anhydrase, synthesized using L-lysine, TETA and NH4Cl, 
respectively. 
Figure 1.7.  The far UV CD spectra of (A) glucose oxidase (black line) before and after 
modification with 20 mM TETA (red line), 100 mM NH4Cl (blue line) and 1 mM PEI 
(Green line); and note that the CD spectra of modified GO are similar to that of the 
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extent. 
Figure 1.8.  Far UV CD spectra of A. carbonic anhydrase and hemoglobin before and 
after modification with 20 mM TETA (red line), 200 mM NH4Cl (blue line) and 200 
mM L-lysine (Green line) recorded in 10 mM K2HPO4 50 mM NaCl pH 7.2 buffer. Note 
that in all cases, the CD spectra of modified enzymes have significant overlaps with 
those of the corresponding unmodified ones. 
Figure 1.9. Comparison of activities of: A. GO B. CA and C. Hb before and after 
chemical modification. Activities were monitored using 1 µM protein solution in 10 
mM K2HPO4 50 mM NaCl pH 7.2 buffer in room temperature according to the 
procedure explained in experimental section.  The particular amines used for the 
modification are as marked in the graph. 
Figure 1.10: The plot of relative specific activities (Relative to the initial activity) of 
unmodified and modified glucose oxidase vs time in hours . Time taken for the 
relative specific activity to be half was take as the half life of each sample. Note that 
the half life of unmodified GO is around 50 hrs and all the modified GOs have half 
life above 160 hours. 
Figure 1.11:  The plot of half life in hours vs isoelectric point of GO and modified 
GO. Note that the half life of unmodified GO is around 50 h and highest half life was 
>300 h, >500% improvement. 
Figure 1.12: The plot of half life vs isoelectric point of hemoglobin and carbonic 
anhydrase. Note that the highest half life among hemoglobin samples were observed 
with lysine modified Hb which has pI around 7.5. Amine modified carbonic 
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anhydrase samples do not show any correlation between the half life and isoelectric 
point. 
Figure 1.13.  Thermograms of modified GO, recorded in 10 mM K2HPO4 pH 7.2, at 
a scan rate of 2 ˚C/min.  GO (black), GO-TETA (red), GO-NH3 (blue) and GO-PEI 
(green). 
Figure 1.14. Molar heat capacity profile of CA (A) and hemoglobin (B), unmodified 
(black), modified with TETA (red), NH4Cl (blue) and L-lysine (green) in 
corresponding buffers at a scan rate of 2 ˚C/min. 
Figure 1.15. (A) .Plot of denaturation temperatures (Tm/˚C) of GO, CA and Hb 
derivatives vs their corresponding half lives ( Unmodified enzyme,  NH4Cl 
derivative,  TETA derivative,  Lysine derivative).  Unmodified and modified 
derivatives of GO show a clear correlation between the denaturation temperature and 
half life while CA and Hb derivatives don’t show any such correlation.  (B) . The plot 
of half life of enzyme vs corresponding amine conjugation of each enzyme. The plot 
indicates higher half life with modified glucose oxidase which has 120 acidic amino 
acids. Hemoglobin and carbonic anhydrase, which contains 60 and 30 acidic amino 
acids respectively, does not show a significant increase in half life. 
Figure 2.1 Absorption spectra of Hb, Hb-PAA and Hb/PAA (1 µM protein) recorded 
in phosphate buffer (10 mM K2 HPO4 pH 7.2, 1 cm pathlength).   The Soret bands of 
Hb (blue line) and Hb-PAA (red line) are nearly superimposable while that of 
Hb/PAA mixture (green line) indicated minor decrease in Soret band intensity. 
Figure 2.2 Gel electrophoresis image of agarose gel run at pH 6.5 tris acetate buffer, 
Hb-PAA conjugate (1), Hb/PAA mixture (2) and Hb (3).  
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Figure 2.3 TEM images of (a) Hb-PAA (0.2 wt% PAA) (b) Hb/PAA (0.2 wt% PAA) (c) 
Hb and (d) PAA (0.2 wt% PAA), stained by RuO4.  
Figure 2.4. Far UV CD spectra (Figure 2.4a) of unmodified Hb (black line) and Hb-
PAA conjugate (red line), as well as those of a physical mixture of Hb and PAA (green 
line). All three samples contained same amount of Hb (4 µM protein in 10 mM K2HPO4 
pH 7.2 buffer). Soret CD (Figure 2.4b) of Hb and Hb-PAA (4 µM protein in 10 mM 
K2HPO4 pH 7.2 buffer). Soret CD peak position of the conjugate is the same as that of 
Hb.  
Figure 2.5. Redox activities of Hb (Figure 2.5a) and Hb-PAA conjugate (Figure 2.5b) 
(1 µM protein in 10 mM K2HPO4 pH 7.2 buffer) as indicated by the Soret absorption 
bands, upon the addition of sodium dithionite and sodium ferricyanide (20 µM). Redox 
activity of the heme moiety is retained in Hb-PAA conjugate.   
Figure 2.6 The peroxidase-like activity of Hb, Hb-PAA and Hb/PAA (1 µM protein) by 
the addition of 2-methoxyphenol (2.5 mM) and H2O2 (1 mM) as monitored by following 
the absorbance of the product at 470 nm (10 mM K2HPO4 pH 7.2 buffer at room 
temperature). Activity of Hb-PAA (red line) is almost the same as that of Hb (blue line) 
or Hb/PAA mixture (green line). Activities were normalized to the concentration of Hb 
in each sample. Conjugation of the polymer with the protein did not alter Hb activity.  
Figure 2.7 The DSC thermograms of Hb, PAA, Hb-PAA and Hb/PAA. The molar heat 
capacity profiles of Hb (8 µM protein, blue line), PAA (4.4 µM, black line), Hb/PAA (8 
µM protein, 4.4 µM PAA, green line), and Hb-PAA (8 µM protein, 4.4 µM PAA, red 
line) recorded in 10 mM K2HPO4 pH 7.2 buffer at a scan rate of 2 ˚C /min.  The 
quantitative values of the corresponding thermodynamic parameters are listed in Table 
1. 
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Figure 2.8 Peroxidase activities after steam sterilization and cooling to room 
temperature. Activities were measured with with1 mM H2O2 and 2.5 mM 2-
methoxyphenol in 10 mM K2HPO4  pH 7.2 buffer, at room temperature. The data has 
been normalized to the concentration of Hb in each sample. Activity of Hb-PAA (broken 
red line) after steam sterilization is similar to the activities of Hb (broken blue line) and 
Hb/PAA (broken green line). There are no measureable differences among the three 
samples.  
Figure 2.9. The effect of pH on heme Soret peak from pH 7 to 11, (Hb (blue line) Hb-
PAA (red line), 4.4µM PAA, 8µM Hb in PBS pH 7.4 buffer at 25°C). The peak shifted 
from 406 nm to higher values upon addition of NaOH and the transition was reversible 
with little or no hysteresis.   
Figure 2.10 Change in specific activity of the Hb-PAA as a function of time. Specific 
activities of Hb (blue line), Hb/PAA mix (green line) and Hb-PAA conjugate (red line) 
are compared, as a function of time. 1 mM H2O2 and 2.5 mM 2-methoxyphenol in 10 
mM K2HPO4 pH 7.2 were used to measure the peroxidase-like activities of the samples. 
Specific activity at time t was divided by specific activity at time 0 to compare the three 
sets of data.  
Figure 3.1. Titration of Hb (486 µM) with PAA (0.7 µM) in PBS, pH 7.4 at 25 ˚C. (A) 
Change in power vs time plot when PAA solution was titrated with Hb solution. (B) 
Enthalpy change vs [Hb]/[PAA] for titration. Red line is the best fit to the data, 
according to the single, identical, non-interacting binding site model. Best fit indicated a 
binding stoichiometry of 14 Hb per mole of PAA, binding constant of 3.2x105 M-1, ∆H 
and ∆S values of -7.4 kcal/mol of Hb bound and 0.1715 cal/mol, respectively. 
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Figure 3.2.  Hb association dissociation curve for 10µM Hb binding to PAA in PBS pH 
7.4 (500µRIU PAA immobilized). (black – Hb binding curve, red- data fit by Scrubber 
software) 
Figure 3.3. Agarose gel electrophoresis of Hb-TETA and Hb-Ammonia derivatives at 
pH 7 (samples spotted at the center of the gel). Lane 1 is Hb and lanes 2-4 are Hb-
TETA40-7, Hb-TETA40-5 and Hb-TETA80-5, respectively, while lanes 5-8 are the Hb-
Ammonia derivatives, Hb-Ammonia400-5, Hb-Ammonia800-5, Hb-Ammonia1k-5, Hb-
Ammonia1.5k-5, respectively, produced under specific reaction conditions. 
Figure 3.4. Agarose gels of chemically modified hemoglobin derivatives at pH 6, 8, and 
9 (A through C respectively). Lane 1 in each gel is Hb and lanes 2, 3, & 4 are Hb-
TETA40-7, Hb-TETA40-5 and Hb-TETA80-5 respectively. Lanes 5-8 are Hb-
NH4Cl400-5, Hb-NH4Cl800-5, Hb-NH4Cl1k-5, Hb-NH4Cl1.5k-5, respectively. Mid 
point of each protein band as indicated was taken as the distance migrated in the agarose 
gel. Distance and charge relationship of the modified Hb derivatives, relative to the 
distance and charge of Hb, were calculated using imageJ 1.46r software from NIH and 
tabulated in Table 3.2. 
Figure 3.5. Agarose gels of chemically modified hemoglobin derivatives at pH 6, 6.8, 
7.5 and 8.7. Lane 1 in each gel is Hb and lanes 2, 3, 4, 5and 6 are Hb-TETA40-7, Hb-
TETA40-5 , Hb-TETA80-5, Hb-TETA60-7 and Hb-TETA60-7  respectively. Mid point 
of the protein band in lane 5 and 6  was taken as the distance migrated in the agarose gel. 
Distance and charge relationship of the modified Hb derivatives, relative to the distance 
and charge of Hb, were calculated using imageJ 1.46r software from NIH and tabulated 
in Table 3.3. 
  xi 
Figure 3.6. Plot of pH vs charge of Hb and Hb-TETA and Hb-NH4Cl derivatives. Y 
Intercept of each curve was taken as the isoelectric point (pI). Charge of each derivative 
at pH 6.4 where ITC measurements were take were also extracted from the plot. 
Figure 3.7. Far UV CD spectra of unmodified Hb (black line), Hb-TETA40-7 (Blue 
line), Hb-TETA40-5 (Red line) and Hb-TETA80-5 (Green line). All samples contained 
same amount of protein in PBS pH 6.4 buffer. Note that the peak positions and 
intensities of Hb did not change upon chemical modification. 
Figure 3.8. Far UV CD spectra of unmodified Hb and Hb-TETA derivatives in the 
absence (black line) and in the presence (Blue dash line) of PAA. All samples contained 
same amount of protein and PAA that was used for ITC measurements and were in PBS 
pH 6.4 buffer. CD spectra imply that there are no major distortions in protein secondary 
structure when bound to PAA. 
Figure 3.9. Soret CD spectra of unmodified Hb and Hb-TETA derivatives in the 
absence (black line) and in the presence (Blue dash line) of PAA. All samples contained 
same amount of protein and PAA that was used for ITC measurements and were in PBS 
pH 6.4 buffer. 
Figure 3.10. A. Change in power due to the addition of Hb-TETA80-5 (60 µM) to PAA 
(9 µM, polymer)  (black curve), the dilution of Hb-TETA80-5 (60 µM)   (blue curve), 
and dilution of PAA (9 µM)   (red curve). B. Change in power due to the binding of Hb-
TETA80-5 to PAA, after correcting for the dilutions of Hb-TETA80-5 and PAA (PBS, 
pH 6.4, 25 ˚C).  These peaks were integrated to extract the corresponding ∆H values. 
Figure 3.11. Binding enthalpies of Hb-TETA (blue dots) and Hb-Ammonia derivatives 
(black dots) (60 µM) to PAA (9 µM) as a function of their charge.  Slopes of the linear 
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fits to the TETA and ammonia derivatives are – 3.8 and -1.0 kcal/mol per unit charge, 
respectively (PBS, pH 6.4, 25 ˚C). 
Figure 3.12. Comparison of activities of modified and unmodified Hb (1 µM) in the 
presence and absence of PAA (0.15 µM) in PBS buffer pH 6.4 at room temperature. 
Figure 3.13. Relative activities of Hb-derivatives (1 µM) in the presence or absence of 
PAA (0.15 µM), with respect to that of Hb, in PBS, pH 6.4, at 25 ˚C. 
Figure 4.1: Agarose gel of unmodified BSA (lane 1) and BSA modified with TETA 
(cBSA)  (lanes 2, 40 mM Tris acetate, gel run at pH 6) and samples were loaded into 
wells at the middle of the gel (dotted line). 
Figure 4.2 : Overlap of absorbance  and emission  spectra of the four chromophores 
used to make the artificial antenna complex. Abbreviations of dyes are ; H for Hoechst 
(Blue), C for C540A (Green), F for Fluorescein (yellow) and  R for Rhodamine (red). 
Figure 4.3 : Emission spectra of the self-assembled system showing the contribution of 
each chromophore to the energy transfer cascade. (Abbreviations of dyes are ; H for 
Hoechst, C for C540A, F for Fluorescein and  R for Rhodamine). A) Note that the 
Hoechst emission was quenched and Rhodamine emission was increased in the presence 
of primary and secondary acceptors, C540 and Fluorescein respectively. B) Clear 
evidence of step-wise energy transfer cascade has shown since elimination of each 
intermediate results in decrease in Rhodamine emission and increase in corresponding 
donor emission. 
Figure 4.4. A) Increase in quenching of Fluorescein emission by increasing Rhodamine 
concentration. B) Plot of ln Φ0/Φ  vs quencher (Rhodamine) concentration. Note that the 
plot is non linear. C) Plot of  ln Φ0/Φ  vs quencher (Rhodamine) concentration. Linear 
plot implies the quenching follows Perrin model. 
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Figure 4.5  A) C540 emission was decreased concomitantly by increasing quencher 
(Fluorescein) concentration. B) Plot of  ln Φ0/Φ  vs quencher (Fluorescein) 
concentration. Quenching radius between C540 and Fluorescein was extracted from this 
Perrin plot.  C). Decrease of emission spectra of Hoechst due to the increase in C540 
which as the immediate acceptor for Hoechst emission according spectra overlaps. D) 
Plot of  ln Φ0/Φ  vs quencher (C540) concentration. Quenching radius between Hoechst 
and C540 was extracted from this Perrin plot. 
Figure 4.6 Energy transfer efficiency as a function of donor concentrations monitored 
using excitation spectra. Emission was monitored at 650 nm.  A) Increase in 
concentration of Hoechst. B) Increase in concentration of C540A. C) Increase in 
concentration of Rhodamine. 
Figure 4.7 SEM image of protein-DNA-Dye film. 
Figure 4.8 Emission intensity at 586 nm ( emission of Rhodamine) vs time of 
incubation of DNA/cBSA/dye film and DNA/cBSA/Rhodamine film at 80 0C. Films 
were cooled down to room temperature for 2-3 hours before taking the collecting 
spectra. 
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Chapter 1: Chemical Modification of Proteins Using Polyamines: As a 
Tool to Improve Enzyme Stability  
1.1 Abstract 
 Enzyme-water interface could influence enzyme stability, and controlling the 
nature of this interface is a challenge.  Here, we tested the hypothesis that net charge 
at the enzyme-water interface contributes to protein stability by systematically 
controlling this interface. Controlled amidation of the surface carboxyl groups of 
glucose oxidase (GO), carbonic anhydrase (CA) and hemoglobin (Hb) by reaction 
with NH4Cl, triethylenetetramine (TETA), L-lysine or polyethyleneimine (PEI) 
resulted in chemically modified derivatives of these enzymes. Amidation, as 
expected, raised the isoelectric points (pI) of all 12 derivatives, but it did not alter 
enzyme structure or their catalytic activities to a significant extent, as monitored by 
gel electrophoresis, circular dichroism and activity studies. Storage half lives of all 
12 enzyme derivatives increased, consistent with modified enzyme charge, and we 
show that protein stability can be exquisitely controlled by chemical modification.  
Thus, enzyme-water interface plays a very important role in controlling enzyme 
stability and this physical insight provides benign chemical methods to increase 
enzyme stability in a systematic manner.  Control of enzyme stability is important 
for applications in biocatalysis and biosensing and current results point to new 
opportunities to control enzyme stability.  
 
  2 
1.2 Introduction 
 
 Chemically modified enzymes provide unique opportunities to control enzyme 
behavior at the molecular level.  For example, the surface residues of enzymes were 
chemically modified to facilitate the formation of novel enzyme-enzyme and 
enzyme-DNA complexes, which are not formed otherwise.1,2 Chemically modified 
enzymes also provided opportunities to enhance their solubility in organic media.3,4,5  
Conjugation of polycations, polyols, small molecules or peptides to enzymes has 
been used to increase the affinities these enzymes for selected targets.6,7,8  
Ethylenediamine modified bovine serum albumin (BSA), for example, showed 
stronger affinity for afflotoxin and increased antibody production.9 Enzymes 
conjugated with amines showed high efficiency for the cellular uptake of DNA, 
proteins and small molecules, due to favorable interactions of the newly introduced 
amine groups with the negatively charged cell membranes.10.11,12,13  Amine 
conjugates of catalase and GO bind to the epithelial cells and prevent oxidative 
cellular damage.14,15,16 Carboxyl-modified pepsin indicated enhanced thermal 
stability, but the underlying reasons for increased stability are not investigated.17 
Here, we systematically control enzyme-water interface by chemical modification 
and show that this molecular control provides new opportunities to improve enzyme 
stability in a systematic manner.  
Our hypothesis is that decrease of charge at the enzyme-water interface, via 
limited chemical conversion of the surface carboxylate functions (Scheme 1.1), 
would stabilize the native state of the enzyme.  This is fundamentally due to a 
decrease in the charge-charge repulsion (coulombic explosion) in the native state and 
this repulsion contributes to the propensity for denaturation.18   
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Scheme 1.1: Amidation of the carboxyl groups of enzymes using EDC 
chemistry, under mild reaction conditions. 
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Conversely, a reduction in charge-charge repulsion would stabilize the 
enzyme.  For the current study, we have chosen glucose oxidase (GO), hemoglobin 
(Hb) and carbonic anhydrase (CA), which carry 126, 60 and 30 carboxyl functions, 
respectively.  Limited conversion of these carboxyl groups to the corresponding 
amides, under controlled conditions, is expected to reduce charge repulsion by 
replacing negatively charged carboxyl groups by charge-neutral amide functions.  
Note that all three enzymes are negatively charged at pH 7, and alleviation of this 
unfavorable charge repulsion is expected to stabilize the native state and thereby 
increase its stability.  
            The amidation was carried out by the reaction of COOH groups with NH3, 
triethylenetetrammine (TETA), L-lysine or polyethyleneimine (PEI), to produce the 
corresponding -CO-NH2, -CO-TETA, -CO-Lysine and -CO-PEI, respectively.  Both 
TETA and PEI provide additional basic sites for side chain protonation and they 
have the potential for additional reduction of negative charges.  Controlled carboxyl-
modification, therefore, can lower the net negative charge on the enzyme, while 
decorating the surface with strongly polar, amide groups.  All 12 carboxyl-modified  
enzyme derivatives reported here, showed increased stability, and stabilities 
correlated with the extent of charge reduction at the enzyme-water interface.  Details 
of our investigations are presented. 
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1.3 Experimental 
1.3.1 Materials:  Glucose oxidase (GO, Aspergillus niger), peroxidase type 1 from 
horseradish (HRP), bovine met-hemoglobin (Hb), triethylenetetraamine (TETA), L-
lysine, NH4Cl, glucose, sodium phosphate, NaCl, acetonitrile, PEI (mol. wt. 2000) 
and p-nitrophenyl acetate were purchased from Sigma-Aldrich Co (St. Louis, MO).  
Bovine carbonic anhydrase (CA) from US biological (Swampscott, MA) and N-(3-
dimethlaminopropyl)-N-ethylcarbodiimide (EDC) from TCI America  (Portland, 
OR). 
 
1.3.2 Chemical Modification of Enzymes: Surface groups of enzymes were 
modified by reacting the carboxyl functions of enzymes with appropriate amines by 
adopting reported procedures.19 (25). GO (3 mg/ml) in deionized water (DI) was 
stirred with TETA (20 mM, pH adjusted to 5) for half an hour followed by the 
addition of EDC (10 mM). The mixture was stirred for four hours at room 
temperature and unreacted EDC, TETA and other byproducts were removed by 
dialysis against  phosphate buffer (K2HOP4 (10 mM), NaCl (50 mM) pH 7.2).  This 
approach was also used for enzyme modification with other amines.  The degree of 
modification was carefully controlled by adjusting amine concentration, pH of the 
reaction mixture, enzyme concentration and the reaction time until all the natural 
enzyme has been consumed to form the modified enzyme.  These details are 
collected in Table 1.1.  Modified enzymes were examined by native agarose gel 
elctrophoresis21 and SDS PAGE22 for purity, charge modification and for the 
presence of any crosslinked products.  
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Table 1.1. Reaction conditions used for the bioconjugate preparation.  Optimized 
concentrations of amines (mM) and enzymes (2 mg/ml) (pH 4.5 or 5.0) in K2HPO4 
(10 mM), NaCl (10 mM) at 25 0C. Reaction time was 4 hours.  
 
Enzyme /Amine 
Used (2 mg/ml) 
NH4Cl   
pH 4.5 
TETA 
pH 5.0 
PEI 
pH 5.0 
L-Lysine 
pH 5.0 
Glucose oxidase 100 mM 20 mM 1 mM 100 mM 
Carbonic anhydrase 200 mM 20 mM NA 200 mM 
Hemoglobin 200 mM 20 mM NA 200 mM 
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1.3.4 Agarose Gel Electrophoresis: Native agarose gel electophoresis was 
performed using horizontal gel electrophoresis apparatus (Gibco model 200, Life 
Technologies Inc, MD) and agarose (0.5% w/w) in Tris acetate (40 mM) pH 7.2 
buffer was used. Modified enzymes were loaded with 50% loading buffer (50% v/v 
glycerol and 0.01% w/w bromophenol blue).  Running buffer used for all the 
samples was Tris acetate (40 mM) pH 7.2, and samples have been spotted into wells 
placed at the middle of the gel so that the enzyme could migrate toward the negative 
or the positive electrode depending on its net charge at pH 7.2.  A voltage of 100 V 
was applied for appropriate  duration, which depended on the enzyme and the extent 
of reaction. Gels were stained overnight with 10% v/v acetic acid, 0.02% w/w 
Coomassie blue  and destained in 10% v/v acetic acid over night.   
 
 
1.3.5 SDS PAGE: The purity and the presence of crosslinked products of the 
bioconjugates were also assessed using SDS PAGE by following a reported 
method.22  After synthesis, following dialysis, enzyme samples were completely 
dried in a SpeedVac (Savant Speedvac concentrator, Savant Inc, NY) for 2 h, and 24 
µl of loading buffer (SDS (7% v/v), glycerol (13% v/v), Tris-HCl (50 mM), 
mercaptoethanol (2 % v/v) and bromophenol blue (0.15% v/v) pH 6.8) were added 
to dissolve enzymes. The mixture was heated for 60 seconds in boiling water and 
sample (8 µl) was loaded into 9% acrylamide gel containing separating and stacking 
gels. The separating gel contained acrylamide, gel buffer, 80% glycerol, 10% 
ammonium per sulfate (APS) and TEMED (N, N, N, N-
tetramethylethylenediamine), and deionized water. Stacking gel contained 
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acrylamide, gel buffer, deionized water, 10% APS and TEMED.  Potential of 60 V 
was applied until the dye passed through the stacking gel and after that the voltage 
increased to 110 V for an additional 2 h.  Gel was first stained for 1 h with stain 1 
which contained 20% v/v 2-propanol, 20% v/v acetic acid, 0.02% w/w Coomassie 
Blue and staining was continued with stain ll which contained 20% v/v acetic acid. 
0.02% m/m Coomassie Blue for additional 24 h. Then, gels were destained in 10% 
acetic acid for 24 h and scanned using CanonScan Lide200 scanner.  To estimate the 
molecular weights, a standard curve was plotted by using the mobilities of known 
MW standards.  NIH image v1.1.6 software (NIH, U. S. A) was used to quantify the 
per cent yield of dimerization, if any.  
 
 
 
1.3.6 Determination of the pI of Bioconjugates: Agarose gel electrophoresis was 
performed at specific pH values of the running buffer, in order to determine the 
isoelectric points of the bioconjugates.21  Based on the assumption that the size of 
the modified enzyme is nearly the same as unmodified enzyme, which is a 
reasonable assumption given the small size of the polyamines that are being used for 
modification, the pI values were evaluated.  Charge on the enzyme is proportional to 
its electrophoretic mobility, and when the buffer pH corresponds to the pI of the 
sample, enzyme will have a net charge of zero with no electrophoretic mobility in 
the gel. 
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1.3.7 Determination of amount of TETA reacted using Cu+2 titration: The number 
of TETA molecules reacted per GO molecule was estimated using TETA-Cu 
complexation reaction. After the reaction between TETA and GO in the presence of 
EDC, unreacted TETA was dialysed into DI water. Unreacted TETA was complexed 
with excess Cu+2 for 0.5 h and the TETA-Cu absorption was measured at 260 nm23. 
Amount of unreacted TETA was determined by using a previously constructed 
calibration plot. From the initial mole numbers of TETA and unreacted TETA, the 
number of moles of TETA reacted per mole of GO was estimated. 
 
1.3.8 Circular Dichroism (CD) Studies:  The CD spectra were recorded on a 
JASCO J-710 spectropolarimeter using 4 µM enzyme dissolved in K2HPO4 (10 
mM), NaCl (50 mM), pH 7.2 buffer and the baseline obtained with buffer alone.24  
While collecting data, step resolution was kept at 0.2 nm per data point and scan 
speed was 50 nm/min.  Sensitivity was kept at 20 millidegrees with a bandwidth of 
1.0 nm. Each sample was scanned from 190 to 260 nm and an average of four 
accumulations was recorded using 0.05 cm path length cuvette. 
 
1.3.9 Enzyme Activity Studies: Activities of natural and modified lipase were 
determined using p-nitrophenyl acetate as the substrate by following reported 
methods.25  To the enzyme solution (2 µM) in phosphate buffer (K2HPO4, 10 mM), 
NaCl (50 mM), pH 7.2, p-nitrophenyl acetate (1.6 mM in 5% acetonitrile) was 
added, and product formation has been monitored (absorbance at 410 nm) as a 
function of time.  The kinetic data have been analyzed to calculate specific activities 
from the initial rates of these reactions.   
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 GO activity was determined by following a reported method.26  To GO (1 
µM), in phosphate buffer, was added a solution of glucose (0.2 mM), guaiacol (10 
mM) and horseradish peroxidase (2 µM). Oxidation of the substrate was monitored 
by recording the product absorbance at 470 nm as a function of time. 
 Peroxidase-like activity of Hb was determined by adopting a reported 
method28 . To Hb (0.5 µM, in phosphate buffer) was added o-methoxyphenol (2.5 
mM) and H2O2 (1 mM). and product formation monitored at 470 nm as a function of 
time.   
 Activities of natural and modified CA were evaluated by a reported method, 
with minor modifications.28 To CA (2 µM) in Tris buffer, p-nitrophenyl acetate (1.6 
mM in 5% acetonitrile) was added and the rate of product formation has been 
recorded by monitoring absorbance at 410 nm as a function of time.  
In all activity studies, the kinetic traces were plotted using Kaleidagraph (V. 
4.0) to determine initial rates and specific activities.  Each experiment was repeated 
three times and data have been averaged.  
  
1.3.10 Half-Lives of Enzymes: Enzyme stabilities were measured by monitoring 
their activities as a function of time. Modified and unmodified enzyme conjugates 
were stored at 30 0C and activities have been measured at room temperature at 
intervals of 24 hrs until the activity is closer to zero. All activity studies performed in 
phosphate buffer (K2HPO4 10 mM, NaCl 50 mM, pH 7.2), according to procedures 
described above.  Specific activities vs time were plotted (average of three 
measurements) and time taken to reduce the activity of the bioconjugate to half of its 
original activity (half-life) has been estimated from these data.  
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1.3.11 Differential Scanning Calorimetry (DSC): Thermograms of natural and 
modified enzymes were recorded using a 6100 Nano II differential scanning 
calorimeter (Calorimetry Sciences Corporation, CSC Utah) by following a 
previously reported procedure.29  All solutions were degassed 10 minutes prior to 
loading and constant pressure of 3 atm was applied to prevent solvent evaporation 
during the scan. Baseline was recorded with buffer versus buffer scans, where both 
cells were loaded with 10 mM Na2HPO4 50 mM NaCl pH 7.2 buffer. The cells were 
first equilibrated for 10 minutes at 20˚C and scanned from 20 – 100 ˚C at a scan rate 
of 2 ˚C minute-1.  After the buffer scan, sample cell was emptied, washed, and filled 
with the enzyme solution (4 µM) in phosphate buffer (10 mM Na2HPO4 50 mM 
NaCl pH 7.2). Heating and cooling scans were recorded using the same parameters, 
as the buffer versus buffer scan. During data processing, buffer scan data were 
subtracted from sample scan and normalized to enzyme concentration. The extent of 
reversibility of the transition was checked by repeating the heating scan after the first 
cycle, and none of the samples indicated reversible denaturation.   Hence, only the 
model independent parameters such as denaturation temperature (Tm) and 
ΔHdenaturation (area under the curve) were calculated from the DSC data. 
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1.4 Results  
We tested the hypothesis that charge-charge repulsion contributes 
significantly to enzyme instability (coulomb explosion), and therefore, controlled 
carboxyl-modification with amines could reduce charge and thereby stabilize the 
native state of the enzyme. Our data show that, when modifications are few, mild, 
sparse, and controlled, this approach could produce modified enzymes with 
increased isoelectric points (pI) and enhanced stabilities.  The half lives of the 
modified enzymes correlated with the net charge on the enzyme, and this provided a 
physical insight into controlling enzyme stability by chemical modification.  
 
1.4.1 Synthesis of Chemically Modified Enzymes:  Covalent coupling of amines to 
the carboxyl functions of enzymes was carried out under mild conditions by 
carbodiimide chemistry (Scheme 1.1). Coupling with ammonia, L-lysine, 
triethylenetetramine (TETA) and polyethyleneimine (PEI, mol. wt., 2000), under 
specific conditions, produced enzymes with reduced negative charge.  Care was 
taken not to crosslink the enzymes by using excess of amine and by limiting the 
reaction time.  
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Figure 1.1: Agarose gel of GO (lane 1) and GO modified by reaction 
with L-lysine, NH4Cl and TETA  (lanes 2, 3 and 4, respectively, 40 mM 
Tris acetate, gel has been run at pH 6,) and samples were loaded into 
wells at the middle of the gel (dotted line). 
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Reaction progress was monitored by agarose gel electrophoresis, where the 
protein is subjected an electric filed.  Net charge on the enzyme is proportional to the 
distance of its migration in the agarose gel and the direction of migration is 
indicative of the sign of charge.  For example, GO is negatively charged at pH 6, and 
it migrated toward the positive electrode (Figure 1.1, lane 1).  Chemical conversion 
of a portion of its carboxyl groups to amides with L-lysine, ammonia or TETA 
resulted in GO-derivatives that migrated less toward the positive electrode (lanes 2 
and 3) or started to migrate toward the negative electrode (lane 4).   Thus, reaction 
progress has been monitored using agarose gel electrophoresis and the reaction was 
stopped when the charge is adjusted as desired (Figure 1.1). 
Since the samples were spotted at the center of the gel, the enzyme could 
migrate toward the anode or the cathode depending on the sign of its charge, at the 
pH of the buffer used for electrophoresis.  The gel obtained at pH 6 (Figure 1.1) 
shows complete conversion of GO to the modified enzyme, and none of the lanes 
indicated unreacted GO.  Thus, net charge on GO diminished in the case of lane 2 
and charge on modified GO in lane 4 indicated a net positive charge.  The 
attachment of amines can potentially introduce a number of positive charges per 
conjugation event, and this provided a simple method to systematically adjust 
enzyme charge at a given pH, as desired. 
In a similar fashion, controlled chemical modification with the above four 
amines was carried out with CA and Hb, and in all cases the reaction conditions 
were optimized (Table 1.1) for the complete conversion of the unmodified enzyme 
to the corresponding cationized enzymes.  The products were examined in agarose 
gel electrophoresis (Figure 1.2), and amidation was stopped when all the starting 
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material has been consumed.  Next, we examined the net charge of the modified 
enzyme as a function of pH to estimate the isoelectric points of these bioconjugates.  
 
 
(-) Electrode                             (-) electrode 
           
       (+) electrode                            (+) electrode 
  1       2        3       4                 1      2       3        4 
A. CA (pH 8)                               B.  Hb (pH 8) 
 
 
Figure 1.2. A. Agarose gel of unmodified carbonic anhydrase  (lane 1), and 
modified CA,  (lanes 2, 3, 4) synthesized with L-lysine, TETA and NH4Cl, 
respectively according to the conditions listed in Table 1. (running buffer, 40 
mM Tris acetate, pH 8). B. Agarose gel of unmodified hemoglobin (lane 1), and 
modified hemoglobin,  (lanes 2, 3, 4) synthesized with TETA, L-lysine and 
NH4Cl respectively according to the conditions listed in Table 1. (running 
buffer, 40 mM Tris acetate, pH 8). 
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1.4.2 Characterization of Modified Enzymes: The newly produced enzyme 
derivatives are characterized by a battery of biophysical and biochemical techniques, 
prior to measuring their thermodynamic stabilities.  These included the 
determination of isoelectric points, circular dichroism spectra, and activity studies. 
 
1.4.2.1 Isoelectric Points and Charge determination:  We further characterized 
modified enzymes by determining their isoelectric points (pI), the pH where the 
enzyme net charge is zero.  When pH of the running buffer is the same as the pI of 
the enzyme, net charge on the enzyme must be zero, and therefore, the sample 
should not move out of the wells, when the electric field is applied.  On the other 
hand, when the net charge on the enzyme is not zero at a given pH, it will migrate 
out of the wells either toward the positive electrode or the negative electrode 
depending on the sign and magnitude of its charge.  Thus, gel electrophoresis is a 
simple and quick method to determine the pI values by running a set of agarose gels 
at specific pHs.   
Accordingly, we ran multiple agarose gels at specific pHs and a 
representative set of gels are shown in Figure 1.3, where the sample is loaded into 
the wells at the center of each gel (the thin dotted line). 
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A.  GO                                    pH 7                          pH 8                                       
                                
B. CA 
     pH 4                 pH 5                 pH 6               pH 7                pH 8     
(-) electrode       
 
(+) electrode 
 
              C. Hb 
      pH 4                      pH 5                        pH 6                     pH 7                           
(-) electrode       
 
(+) electrode 
  
Figure 1.3A. Agarose gels of modified GO (lane 1) and GO modified by reaction 
with with L-lysine, NH4Cl and TETA  (lanes 2, 3 and 4, respectively, 40 mM Tris 
acetate, gels were run at specific pHs, as indicated).   B. Agarose gels of modified 
CA in 40 mM Tris acetate at room temperature. In each gel, lane 1 contained to 
unmodified CA, lane 2 is CA modified with 20 mM TETA and lanes 3 and 4 
were CA modified with 200 mM L-lysine and 200 mM NH4Cl, respectively. C. 
Agarose gels of modified Hb in 40 mM Tris acetate at room temperature. In each 
gel, lane 1 contained unmodified Hb, lane 2 is hemoglobin has been modified 
with 20 mM TETA at pH 5 and lanes 3 and 4 were Hb modified with 200 mM 
lysine (pH 5) and 200 mM NH4Cl (pH 5), respectively.  
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 Lane 1 in all gels contained unmodified enzyme while lanes 2-4 contained 
enzymes modified with L-lysine, NH4Cl and TETA, respectively. The pI values 
were deduced from these gels by monitoring the distance of migration in each lane 
as a function of the pH of the buffer used for electrophoresis.  For example, GO, CA 
and Hb indicated pI values of 4, 6, and 7 which are in good agreement with literature 
values of 4.2, 5.6 and 7, respectively.30  Lanes 2-4 in each gel correspond to enzymes 
modified with L-lysine, NH4Cl and TETA, respectively.  The pI values estimated 
from these gels are collected in Table 1.2 and the pI values are to be compared with 
the corresponding pKa values of amines used, L-lysine (2.2, 10.53), ammonia (7) 
and TETA (3.37, 6.62, 9.09, 9.69), respectively31.  This small set of modified 
enzymes (12) along with the 3 unmodified ones, with pI values over a wide range (4-
10), are suitable to test the above hypothesis. 
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Table 1.2. Isoelectric points of modified and unmodified enzymes as estimated by 
agarose gel electrophoresis.  
 
Enzyme/Amine 
Used 
Unmodified L-Lysine NH4Cl TETA 
Glucose 
oxidase 
~432 ± 0.25 5 ± 0.5 6 ± 0.5 7 ± 0.7 
Carbonic 
anhydrase 
5.633 6-8 > 10 > 10 
Hemoglobin 6.534 7-8 7-8 > 8 
 
 
 
 
 
The net charge on chemically modified GO samples were estimated from the 
distance of migration of that sample, when compared to that of unmodified GO and 
from the known charge of unmodified GO at the corresponding pH35 (Figure 1.4).  
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Figure 1.4. Agarose gels of GO (lane 1) , GO-Lysine  (lane 2) , GO-NH4Cl  
(lane 3) and GO-TETA (lane 4) in 40 mM Tris acetate, gels were run at 
specific pHs, as indicated.When pI of the protein equals to the pH of the 
running buffer, protein does not move out of the well, which are located in 
the middle of the gel. Mid point of each protein band as indicated was taken 
as the distance migrated in the agarose gel. Distance and charge relationship 
of the modified GO derivatives, relative to the distance and charge of 
unmodified GO, were estimated using imageJ 1.46r software from NIH and 
average charge at pH 7 was tabulated in Table 1.3 
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The pI values of GO conjugates obtained from agarose gel electrophoresis 
were confirmed by plotting the net charge on the GO derivative as a function of the 
pH. The pI of each conjugate was extracted from the y intercept of the linear plot, 
which signifies the net charge on the conjugate is zero. The observed pI value of GO 
(3.75) is in agreement agreed with the reported value of 3.9 (Figure 1.5). 
 
 
 
A  B  
C  D  
Figure 1.5. Plot of pH vs charge of (A) GO,  (B) GO-Lysine, (C) GO-
NH4Cl and (D) GO-TETA. The Y-intercept of each is the corresponding 
isoelectric point (pI).  
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The net charge on each sample, as estimated above, was used to calculate the 
number of COOH groups that have been modified, in each case. For example, GO-
L-lysine had a net charge of -27, reduced from -65, due to the covalent linking of L-
lysine to the COOH groups of GO. According to the known pKa values of L-Lysine 
(2.2, 10.53), both its amine and COOH groups will be ionized and hence, each L-
lysine attachment would lower the charge by one unit. Thus, charge reduction from -
65 to -27 would require the reaction of 38 COOH groups (65-27=38) with L-Lysine. 
Similarly, the number of COOH groups modified by the attachment of NH3 and 
TETA were determined using corresponding pKa values of ammonia (7) and TETA 
(3.37, 6.62, 9.09, 9.69) to be 50 and 30, respectively (Table 1.3). The number of 
COOH groups modified by TETA, obtained from gel electrophoresis was cross 
checked by the Cu(II) titration method. TETA that was left behind after the reaction 
was separated by dialysis and titrated with Cu(II).  From the absorbance of the 
TETA-Cu complex at 260 nm and a previously determined calibration graph, the 
amount of unreacted TETA has been estimated. The value obtained from Cu(II) 
titration is 31 ± 6 which is comparable to 30, the value obtained from the gel 
electrophoresis. 
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Table 1.3 Isoelectric points, net charge at pH 7 and the number of carboxylic acid 
groups modified for each modified GO sample.  
 
Sample Isoelectric 
point (pI) 
Enzyme 
charge 
at pH 7 
Number of 
COOH groups 
modified  
GO 3.9 -65 0 
GO-100mM L-lysine 5.4 -27 38 ± 4 
GO-100 mM NH4Cl 5.9 -16 50 ± 6 
GO-20 mM TETA 7.2 +10 30 ± 6 
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            The chemically modified enzymes were further examined by SDS PAGE to 
make sure that the chemical modification did not produce significant amounts of 
enzyme-enzyme cross links.  
 
1.4.2.2. SDS PAGE: Chemical modification with multifunctional amines such as L-
lysine, TETA, or PEI could result in the crosslinking of two or more enzyme 
molecules, and hence, the reaction mixture has been examined by SDS PAGE to 
examine the extent of crosslinking, if any (Figure 1.6). Lane one in each gel 
contained the molecular weight markers in kD, lane 2 contained unmodified enzyme, 
and lanes 3-6 contained enzymes modified with TETA, PEI, NH4Cl and L-lysine, 
respectively.  Modified GO, for example, indicated predominantly the monomeric 
form.  There has been some cross linking in specific cases, but extent of crosslinking 
has been minimal.  
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A. GO modification               
B. Hb modification            
C.  CA modification           
 
Figure 1.6. SDS PAGE of A. the modified glucose oxidase. Lane, 1 is the 
molecular weight marker and lane 2 is unmodified glucose oxidase. Lanes 3 to 6 
are glucose oxidase samples modified with TETA, PEI, NH4Cl and L-lysine, 
respectively.   The extent of crosslinking in each of these lanes is indicated under 
the gel; B. modified hemoglobin, Lane 1 is the molecular weight marker and 
lane 2 is unmodified hemoglobin. Lanes 3 to 5 are modified carbonic anhydrase, 
synthesized using L-lysine, TETA and NH4Cl, respectively; C. modified 
carbonic anhydrase, Lane 1 is the molecular weight marker and lane 2 is 
unmodified carbonic anhydrase. Lanes 3 to 5 are modified carbonic anhydrase, 
synthesized using L-lysine, TETA and NH4Cl, respectively. 
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1.4.2.3 CD Studies: The CD spectra in the deep UV region (190-250 nm) of enzymes 
are characteristic of their secondary structure,36 and significant decreases in the 
intensities of these CD bands or shifts in the peak positions would indicate of loss of 
secondary structure, and secondary structure is critical to maintain biological 
activities of modified enzymes. 
 
The CD spectra of GO modified with NH3, TETA and PEI are shown in 
Figure 1.7, and they are comparable to the CD spectrum of unmodified GO (black 
line) recorded under the same conditions of concentration, path length, buffer and 
pH.  These data clearly show that there have been no significant changes in the 
secondary structure of modified GO. 
Similarly, the CD spectra of modified CA and Hb samples are compared with 
those of the corresponding unmodified proteins (Figure 1.8), and the spectral shape 
and intensities at 210 and 222 nm are comparable.  The molar ellipticities of the 
samples are collected in Table 1.4 for comparison.  The data show that careful, 
controlled chemical modification can be nearly benign.  Next, we examined 
activities of modified enzymes to evaluate the extent of their activity retention 
despite these small changes in the CD spectra. 
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Figure 1.7.  The far UV CD spectra of (A) glucose oxidase (black line) before and 
after modification with 20 mM TETA (red line), 100 mM NH4Cl (blue line) and 1 
mM PEI (Green line); and note that the CD spectra of modified GO are similar to that 
of the corresponding GO, which indicates retention of native-like structure to a 
significant extent. 
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   A.Hb                        
B.CA                                 
Figure 1.8.  Far UV CD spectra of A. carbonic anhydrase and B. hemoglobin 
before and after modification with 20 mM TETA (red line), 200 mM NH4Cl 
(blue line) and 200 mM L-lysine (Green line) recorded in 10 mM K2HPO4 50 
mM NaCl pH 7.2 buffer. Note that in all cases, the CD spectra of modified 
enzymes have significant overlaps with those of the corresponding unmodified 
ones. 
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Table 1.4. Molar ellipticities (per µM per cm) of natural and modified enzymes. 
Enzymes used (4 µM) were in K2HPO4 (10 mM)  NaCl (10 mM) pH 7.2 buffer.   
 
Enzyme/Amine Used Unmodified NH4Cl TETA PEI L-Lysine 
Glucose oxidase 
208 nm 
210 nm 
 
-21 
-20 
 
-25 
-21 
 
-25 
-24 
 
-23 
-20.6 
 
NA 
Hemoglobin 
208 nm 
220 nm 
 
-70 
-74 
 
-70 
-77 
 
-60.7 
-65 
 
NA 
 
-60.7 
-65 
Carbonic anhydrase 
197 nm 
212 nm 
 
8.6 
-14.6 
 
13.7 
-16.3 
 
13.5 
-14.7 
 
NA 
 
6.0 
-18.5 
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1.4.2.4.Activity Studies:  The activities of natural and modified GO samples are 
monitored using glucose as the substrate (Figure 1.9A).  Addition of glucose to a 
mixture of GO, HRP and guaiacol in phosphate resulted in rapid generation of the 
oxidation product, which has characteristic absorption maximum at 470 nm.  The 
data show the facile oxidation of guaiacol by hydrogen peroxide catalyzed by HRP, 
where hydrogen peroxide has been produced by the catalytic oxidation of glucose by 
ambient oxygen, catalyzed by GO. 
        The initial rates of substrate conversion to the products by GO, Hb and CA and 
their derivatives were extracted from the kinetic traces of activities. Only in the case 
of amine modified Hb, the activity is decreased significantly.  In all other cases, 
activities are comparable to those of the unmodified enzymes.  Thus, chemically 
modified samples were characterized by a number of methods and the data show that 
modification was nearly benign to alter the net charge without significantly altering 
native-like structure or biological activities.   
 
1.4.3 Evaluation of Enzyme Stability as a Function of pI values: This small set of 
enzymes was used to test the hypothesis that enzyme stability is directly related to 
enzyme charge by two distinct approaches.   
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A B
 
C 
 
 
Figure 1.9. Comparison of activities of: A. GO B. CA and C. Hb before and after 
chemical modification. Activities were monitored using 1 µM protein solution in 
10 mM K2HPO4 50 mM NaCl pH 7.2 buffer in room temperature according to 
the procedure explained in experimental section.  The particular amines used for 
the modification are as marked in the graph. 
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1.4.3.1.Storage stability: Storage stabilities of enzymes are usually low, and they 
often require to be stored under refrigerated conditions. To check for improvements 
in enzyme stabilities predicted by the above hypothesis, we examined activities of 
our samples after storing them at 30 ˚C pH 7.2, phosphate buffer, for extended 
periods of time.  Specific activity vs storage time was plotted for each sample 
(Figure 1.10) and time taken to reduce the activity by half  (half life) has been 
estimated from these plots.  
The half lives of modified GO samples, for example, are plotted as a function 
of their isoelectric points which showed substantial improvement, as the pI increased 
from 4 to ~7 (Figure 1.11).  The stabilities have been monitored for nearly 350 h.  
Note that maximum storage stability was achieved for GO-TETA derivative, with a 
pI of ~7, among all the GO-derivatives.   The increase is measured as (τ-τo/τo) 
>500% where τo is half life of unmodified enzyme and τ is the maximum half life of 
the modified enzymes. The observed trend is GO-TETA > GO-L-lysine > GO-L-
Lysine >> GO For example, GO lost 50 % of its initial activity after 50 h and all the 
modified GO samples indicated half lives  >250 h.  The lowest stability was noted 
with GO which has a pI of 4 as well as the highest charge at pH 7.  The highest half 
life was observed with TETA modified GO, with a pI of ~7 and least amount of 
charge at pH 7.  Therefore, GO-TETA had the lowest net charge and the longest half 
life with a 500% increase in half life over the unmodified GO.   
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Figure 1.10: The plot of relative specific activities (Relative to the 
initial activity) of unmodified and modified glucose oxidase vs 
time in hours . Time taken for the relative specific activity to be 
half was take as the half life of each sample. Note that the half life 
of unmodified GO is around 50 hrs and all the modified GOs have 
half life above 160 hours. 
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Figure 1.11:  The plot of half life in hours vs isoelectric point of GO 
and modified GO. Note that the half life of unmodified GO is around 50 
h and highest half life was >300 h, >500% improvement. 
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Improvements in storage half lives were also observed with Hb derivatives 
when compared to that of Hb (Table 1.5).  Stabilities are in the order Hb-L-Lysine > 
Hb-NH3 > Hb-TETA > Hb over a range of 57 for Hb (pI 6.5) to 73 h for Hb-L-
Lysine (pI of ~7.5).  The maximum increase in half life for Hb derivatives is ~28%, 
not as much as in the case of GO derivatives (>500%).  In contrast, all CA 
derivatives indicated storage half lives that are essentially the same, within our 
experimental error.  The plots of half life vs isoelectric points of Hb and CA 
derivatives are shown in Figure 1.12 for comparison.   
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Table 1.5: Half-lives of chemically modified and unmodified CA, Hb and GO in h. 
Enzymes used (1 µM) were in K2HPO4 (10 mM )  NaCl (10 mM ) pH 7.2 buffer. 
Enzymes were stored at 30 0C water bath and measure the activity at room temperature. 
 
 
Enzyme/Amine Used  Unmodified NH4Cl   TETA  L-Lysine 
Glucose oxidase 51 ± 12 286 ± 5 310 ± 5 257 ± 11 
Hemoglobin 57 ± 0.3 70 ± 0.1 60 ± 0.1 73 ± 0.2 
Carbonic anhydrase 45 ± 0.1 46 ± 0.1 47 ±1 46 ±0.1 
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Figure 1.12: The plot of half life vs isoelectric point of hemoglobin and carbonic 
anhydrase. Note that the highest half life among hemoglobin samples were 
observed with lysine modified Hb which has pI around 7.5. Amine modified 
carbonic anhydrase samples do not show any correlation between the half life and 
isoelectric point. 
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These data clearly show that the general trend of increase in stabilities of all 
derivatives is: GO-derivatives >>> Hb-derivatives > CA-derivatives.  Overall, the 
data show that half lives of both GO and Hb derivatives increased by modification, 
and these roughly correlated with the extent of reduction in the net negative charge 
of these molecules. Encouraged by these data, we next examined the thermal 
stabilities of the bioconjugates by differential scanning calorimetry for further 
insight. 
 
 
1.4.3.2 Thermodynamic stability:  
Differential scanning calorimetry is a direct method to determine the denaturation 
temperature (Tm) and the corresponding enthalpy of denaturation (∆H), even when 
the thermal transitions are not reversible. Comparison of DSC thermograms of GO 
and modified GO are shown in Figure 1.13.  Thermograms of modified GO are 
consistently shifted to higher temperatures by ~7˚C, when compared to that of GO 
(black line).  For example, the peak transition temperatures (Tm) for these 
derivatives increased from 63 ˚C for GO to 70 ˚C for GO-NH3.  These changes are 
nominal but they are in the right direction, and all three derivatives indicated 
higher Tm values than the unmodified GO.  
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Figure 1.13.  Thermograms of modified GO, recorded in 10 mM K2HPO4 pH 7.2, at 
a scan rate of 2 ˚C/min.  GO (black), GO-TETA (red), GO-NH3 (blue) and GO-PEI 
(green). 
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The DSC thermograms of Hb and CA derivatives were also recorded to test 
the influence of chemical modification on thermal stabilities (Figure 1.14).  The 
peak transition temperatures for Hb-derivatives and CA-derivatives remained 
essentially the same as those of the corresponding unmodified proteins (Table 1).  
Thus, the storage half lives are much more sensitive to enzyme modification than the 
denaturation temperatures. 
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A. CA 
 
 
                  
B. Hb                                                                    
Figure 1.14. Molar heat capacity profile of CA (A) and hemoglobin (B), 
unmodified (black), modified with TETA (red), NH4Cl (blue) and L-lysine 
(green) in corresponding buffers at a scan rate of 2 ˚C/min. 
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The DSC curves were further analyzed to estimate the integrated area under 
the curve (∆H), and the corresponding enthalpies of denaturation (ΔHdenaturation) are 
collected in Table 1.6. The denaturation enthalpies of the bioconjugates are 
comparable to those of the unmodified enzymes or larger, in specific cases.  With 
TETA-modified GO, for example, the denaturation enthalpy increased substantially, 
while in case of TETA-modified Hb the lowest value has been noted.  In all other 
cases, the differences between the modified and unmodified enzymes are not 
substantial. 
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Table 1.6.  Enthalpy of denaturation (ΔHdenaturation in kcal/mol) and denaturation 
temperatures (in parenthesis/˚K) of unmodified and modified enzymes. GO and CA 
samples (4 µM) were in K2HPO4 (10 mM) NaCl (10 mM) pH 7.2 while Hb samples 
(4 µM) have been examined in K2HPO4 (10 mM). 
 
Enzyme /Modifier Unmodified NH4Cl TETA L-Lysine PEI 
Glucose Oxidase 221 
(63 ± 1.0) 
170 ± 46 
(70 ± 1.1) 
332 ± 46 
(69 ± 1.0) 
NA 330 ± 112 
(69 ± 1.0) 
Hemoglobin 74 
(66 ± 0.14) 
87 
(65 ± 0.3) 
60 
(64 ± 1.0) 
78 
(66 ± 1.3) 
NA 
Carbonic 
Anhydrase 
92 
(69 ± 1.4) 
88 
(65 ± 2.0) 
84 ± 18 
(67 ± 0.35) 
59 
(67 ± 1.0) 
NA 
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1.5 Discussion 
Chemically engineered enzymes can provide a simple method to modify their 
surface residues, alter enzyme-water interface, and in turn, alter their structure, 
activities and stabilities.  But the extents of these changes are not well documented.  
A clear understanding of the basis for these changes at the molecular level will be a 
major break through in obtaining control over types and extents of modifications 
required for the desired outcomes.  The main focus in the area of chemical 
modification of enzymes, however, has been largely limited to the applications of the 
modified enzymes but not their stability or the underlying causes for their altered 
behavior.38,39  In the current study, we have systematically altered the enzyme 
surface residues with increasing numbers of amines carrying increasing numbers of 
amine groups and examined their influence on key properties of modified enzymes.  
Carboxyl conversion to amides resulted in the elevation of enzyme pI values, and 
this is due to the removal of negative charge of each carboxyl group by converting it 
to the corresponding amide.  Furthermore, in many cases, there are additional basic 
nitrogens which can be protonated at neutral pH, further reducing the net negative 
charge on the enzyme. Therefore, the increase in the pI depended on the amine used 
as well as the extent of modification carried out.  Thus, enzymes with desired pI 
values can be readily obtained by choosing the appropriate amine and by stopping 
the reaction at the desired stage of charge reduction. Thus, enzyme charge at a given 
pH can be exquisitely controlled depending on the reaction conditions used. 
The chemical modifications carried out are mild enough not to cause any 
significant structural changes in the enzymes, and structure retention is essential for 
the biological activities of the modified enzymes.  Consistent with this idea, activity 
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studies show that essentially all modified enzymes retain their activity above 80% of 
the corresponding unmodified enzymes, except in the case of Hb-L-lysine, which 
retained about 60% activity.  Note that both GO-NH3 and CA-TETA indicated 
activities that are slightly greater than the corresponding unmodified enzymes.   
Most significant feature of modified enzymes is that the storage stability has 
been improved substantially, particularly in the case of GO derivatives.   The 
stabilities correlated strongly with the isoelectric points of the derivatives, and 
highest stability is achieved when the pI equals to the pH of the buffer medium used 
for measuring the stabilities.  This implies that the stability is inversely correlate 
with the charge on the enzyme molecule and highest stability is obtained when the 
charge is close to zero.  Thus, under these conditions, the electrostatic contribution 
for the unwinding of the protein is close to zero, and hence its contribution to 
denaturation is minimized.  This physical insight is significant, and guided our 
design the reaction conditions to adjust the net charge on the derivatives. 
In the case of Hb nd CA the influence of chemical modification is not as 
pronounced as in the case of GO, and this is because the net charge on the 
unmodified molecules is quite small.  This is also indicated by the number of 
carboxyl groups present in Hb and CA which are much less than those of GO.  Thus, 
the electrostatic contributions to the unfolding free energy of these enzymes are not 
significant at neutral pH.  Nevertheless, the stabilities of these derivatives also 
showed small but definite improvements.  Based on these observations, we predict 
that stabilities of Hb and CA derivatives at pH values far from the pI values of the 
unmodified proteins will be substantially better than the corresponding unmodified 
proteins.  This hypothesis will be tested in future studies.   
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In the case of GO, the peak denaturation temperatures are distinctly improved 
but in the case of both Hb and CA they are not significantly different from those of 
the corresponding unmodified proteins, as explained above.  One interesting 
observation was that a plot of Tm vs half life of chemically modified derivatives 
(Figure 1.15) indicated a strong correlation for GO derivatives but those of Hb and 
CA did not show any such correlation. GO-derivatives showed an increase in half 
lives as well as melting temperature (Tm) and Tm is a good measure of their half life, 
vice versa, which is quite useful for optimizing thermal or solution stability of GO 
without compromising its activity. 
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  A       B   
Figure 1.15. (A) .Plot of denaturation temperatures (Tm/˚C) of GO, CA and Hb 
derivatives vs their corresponding half lives ( Unmodified enzyme,  NH4Cl 
derivative,  TETA derivative,  Lysine derivative).  Unmodified and modified 
derivatives of GO show a clear correlation between the denaturation temperature 
and half life while CA and Hb derivatives don’t show any such correlation.  (B) . 
The plot of half life of enzyme vs corresponding amine conjugation of each 
enzyme. The plot indicates higher half life with modified glucose oxidase which 
has 120 acidic amino acids. Hemoglobin and carbonic anhydrase, which contains 
60 and 30 acidic amino acids respectively, does not show a significant increase in 
half life. 
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Additional insight into the stability was gained by correlating the increase in 
stability and number of carboxylic groups in the enzyme (Figure 1.15B). Glucose 
oxidase with 120 aspartic and glutamic acid residues shows the highest storage 
stability. The observation clearly demonstrates the strong correlation of increase in 
stability vs number of carboxyl groups for each substituent, and greater number of 
carboxyl groups provides a greater opportunity for charge neutralization by chemical 
modification.  In addition, carboxyl modification with polyamines provide additional 
opportunities for ion pairing with the surface carboxyl groups, further enhancing the 
stability of the native state.  Since carboxyl-carboxyl repulsion energy (∆Grepl) is 
expected to increase with increasing numbers of carboxyl groups, the above trend 
indicates that enzymes with the largest number of carboxyl groups provide the 
greatest opportunities for increasing stability via chemical modification of these 
groups. 
Stability increases also depended on the type of ligand used for modification, 
and this is expected.  For example, reaction with ammonia would neutralize the 
negative charge due to amidation of the carboxyl groups while reaction with TETA 
would provide additional basic sites for protonation leading to further charge 
reduction.  On the other hand, reaction of each COOH group with L-Lysine would 
effectively reduce the negative charge by one unit but would decorate the enzyme 
with zwitter ionic groups which do not favor enzyme aggregation. 
 Increase in stability of GO and Hb can be explained based on the 
electrophoretic mobilities. For example, when the excess charge on the enzyme is 
neutralized by chemical modification, contribution of ∆Grepl toward the denaturation 
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free energy is minimized, thereby increasing the overall stability. The stability 
measured at pH 7.2 can be explained based on the mobilities of samples in agarose 
gels at this pH, and this provided a simple method to predict stabilities of modified 
enzymes. The phenomenon is clearly visible when the half life is plotted against 
isoelectric point (Figure 1.12). The maximum stability was observed when the 
negative charge on glucose oxidase is completely neutralized by making  ∆Grepl  
equals to zero. The effect of charge neutralization on storage stability is prominent 
when the unmodified protein has a higher negative or positive charge at the pH 
where the stability was measured.  In the case of hemoglobin and carbonic anhydrase 
the effect is low as they have isoelectric points closer to 7. Based on the above 
argument, we can assume that the chemical modification can improve the storage 
stability of hemoglobin and carbonic anhydrase at low and high pHs. The new sight 
provides a handle to increase the storage stability of chemically modified enzymes at 
desired pHs by neutralizing the charge on the surface of the enzyme at the desired 
pH.   Given the above insights into the chemical modification and its influence on 
the deactivation pathways, we predict that current model provides an excellent 
handle to improve enzyme stability and half lives via a chemical route. 
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1.6 Conclusions 
Although chemical modification of enzymes is known for some time, there 
has been no systematic evaluation of the influence of the chemical modification on 
key properties of the modified enzymes, nor there is a systematic study of how side 
chains of increased numbers of amine functions would influence the resulting 
bioconjugates.  A general strategy is described here to systematically control the pI 
of a small set of enzymes by chemical conjugation without compromising their 
structure or biological activities. 
A small set of amines with increasing number of positive charges per chain 
are used successfully, and all the samples examined indicated attributes that are 
comparable to those of the corresponding unmodified enzymes. Modification with 
this small set of ligands show that key properties of the enzyme are essentially 
independent of the amine used.  The pI has been controlled systematically by 
increasing the number of basic groups present in the ligand.  This resulted in the 
production of highly positively charged enzymes (at pH 7) without compromising 
their secondary structure, stabilities or activities.   
We conclude that chemical modification, when done carefully under 
controlled conditions, is a viable method to modulate net charge on enzymes without 
considerable loss in their structure, activity, or stability.  This modulation can in turn 
be used to control enzyme-DNA or enzyme-solid interactions, which will be 
reported in future studies.  Chemical modification, therefore, provides a powerful 
handle to control enzyme properties, and in specific instances, there have been 
increases in activity and stability, which are attractive for biocatalytic applications or 
fundamental studies of chemically modified enzymes. 
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Chapter 2 :  Chemical Modification of Protein Using Poly(acrylic acid) 
 
2.1 Abstract 
Synthesis, characterization and evaluation of a novel polymer-protein conjugate is 
reported here. Covalent conjugation of high molecular weight poly(acrylic acid) (PAA) 
to the lysine amino groups of hemoglobin (Hb) resulted in covalent conjugation of 
hemoglobin to PAA (Hb-PAA conjugate), as confirmed by dialysis and electrophoresis 
studies. Retention of native-like structure of Hb in Hb-PAA was established from Soret 
absorption, circular dichroism studies as well as the redox activity of the iron center in 
Hb-PAA. The peroxidase-like activities of Hb-PAA conjugate further confirmed the 
retention of Hb structure and biological activity. Thermal denaturation of the conjugate 
was investigated by differential scanning calorimetry and steam sterilization studies. The 
Hb-PAA conjugate indicated improved denaturation temperature (Td) when compared to 
that of the unmodified Hb. One astonishing observation was that polymer conjugation 
enhanced Hb-PAA storage stability at room temperature significantly. After 120 hours 
of storage at room temperature, for example, Hb-PAA retained 90% of its initial activity, 
while Hb retained <60% of its original activity, under identical conditions. Our 
conjugate demonstrates the key role of polymers in enhancing protein stability via a very 
simple, efficient and general route. Protein-polymer networks with increased shelf life 
can be produced quickly and economically by this approach for a wide variety of 
applications.  
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2.2 Introduction 
    Soft hybrid materials that are biologically functional, yet possess high mechanical 
strength and remain inert, are important for applications in biocatalysis, sensing, design 
of components for artificial organs and biomarker detection.40,41 Examples of these soft 
hybrid materials include novel protein-polymer covalent conjugates, which combine the 
impressive biological activities of proteins with the tailorable structures and properties 
of synthetic polymers.42 Currently, there are two approaches to achieve this goal: a) 
covalent conjugation of the polymer at particular sites on the protein43,44 and b) random 
conjugation where the protein-polymer conjugation is not at specific sites.45 Both 
approaches aim to synthesize protein-polymer conjugates that protect the hierarchical 
structures and biological activities of proteins46,47,48,49 Polymers have specific, 
controllable properties such as mechanical strength, biocompatibility, and tailorability of 
functional groups. The combined influence of polymer properties and their conjugation 
to proteins can be exploited so that protein properties such as precipitation, unfolding or 
degradation, can be altered in a controlled manner.49 
                   The wide availability of synthetic polymerization techniques allows for the 
preparation of polymers with tunable functionality, molecular weight, cytotoxicity, 
biocompatibility or biodegradability and ability to form nanoscopic structures.50,51,52,53 
The structure, composition and properties of the polymers also determine their 
applications. For example, one of the most commonly used polymers for protein 
conjugation is poly(ethylene glycol) (PEG), which has been attached to numerous 
proteins such as human glucocorticoid receptor, superoxidase dismutase and 
interferons.42 While PEG has attracted much attention for conjugation with proteins, 
other polymers with interesting and highly desired properties are yet to be investigated. 
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Depending on the desired applications, polymers can tailored for biocompatibility, 
biodegradability, physical properties and nanoscale structures such that physical 
properties of protein-polymer conjugates can be controlled systematically.   
 The protein chosen for the current study, hemoglobin (Hb), has been used to develop 
artificial oxygen carriers and biosensors.54,55 Hb is a tetrameric globular protein,56 
responsible for oxygen transport in the blood, and several approaches are being tested to 
use Hb as an artificial blood substitute. Attachment of PEG57 , liposome encapsulation 58 
and entrapment in vesicles59 are some examples. Hb also has a high binding affinity for 
toxic gases such as nitric oxide and carbon monoxide60 and Hb sensors currently use 
liquid crystalline surfactant films, gold colloidal particles61 or polymer films. However, 
some limitations with protein-based sensors are their short shelf life and lack of long-
term stability.62 
             Here, we report a polymer network crosslinked with Hb where the lysine amino 
groups of Hb are covalently attached to the carboxyl functional group of poly(acrylic 
acid, PAA) resulting in a crosslinked polymer-Hb network. Crosslinked hydrophilic 
polymers that utilize PAA are Carbopols, which are being tested for protein delivery63 
, controlled release64 and other biomedical applications. We have chosen to use 450 kDa 
PAA, which is known to have reduced cytotoxicity compared to lower molecular weight 
PAA.41 The use of high molecular weight PAA allows for easy processability compared 
to traditional sensor materials such as metal oxides and solid electrolytes. 65,66,67,68,69 The 
Hb-PAA system described here indicated retention of its biological activity, protein 
secondary structure, and long shelf life compared to unmodified hemoglobin. The details 
of our investigations are described below. 
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2.3 Experimental Details 
2.3.1 Materials.  
  Poly(acrylic acid) (450,000 MW) and 1-ethyl-3-(3-dimethyl aminopropyl) 
carbodiimide hydrochloride (EDC), bovine met-hemoglobin, and 2-methoxyphenol were 
obtained from Sigma Aldrich. Phosphate buffered saline (10 mM PBS, 0.137M NaCl) 
pH 7.4 or 7.2 was used for preparing protein solutions. 
 
2.3.2 Conjugate Synthesis.  
             PAA (137.2 mg, 3.05x10-4 mmol, 450,000 MW) was dissolved in distilled water 
(20 ml) and brought to a pH of 7.0 with concentrated NaOH. EDC (51.8 mg, 2.70x10-
1mmol) dissolved in de-ionized (DI) water (5 ml) was then added and the solution placed 
in an ice bath for 15 min. Hb (65.8 mg, 1.03x10-3 mmol) dissolved in PBS (phosphate 
buffered saline)  (10 mM, pH 7.4, 5 ml) was added slowly with stirring.  Additional PBS 
(20 ml) was added to adjust the PAA weight percent to 0.2%. The solution was then 
allowed to stir overnight while reaching room temperature and dialyzed (100k cut-off) 
for several days. The dialysate was monitored by UV-Vis for Hb, which indicated no 
release of Hb from the bag. In a blank run, when Hb was not conjugated to the polymer, 
large portions of Hb was released from the bag, thus confirming the conclusion that 
EDC coupling was nearly 100% efficient in conjugating the protein to the polymer. 
 
2.3.3 Native Gel Electrophoresis. 
        Native agarose gels were prepared by dissolving agarose (0.5% w/v) (Sigma 
electrophoresis grade) in a hot solution of tris acetate (40 mM, pH 6.5). The gel was run 
in a horizontal gel electrophoresis apparatus (Gibco model 200, Life Technologies Inc, 
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MD) using tris acetate (40 mM pH 6.5) as the running buffer. Samples were loaded into 
the gel with loading buffer (50 % v/v glycerol and 0.01% m/m bromophenol blue) and 
electrophoresis carried out for 30 min at 100 mV at room temperature. The gel was 
stained overnight with 10% v/v acetic acid, 0.02% m/m Coomassie blue and then 
destained with 10% v/v acetic acid for an additional night. The gel was photographed 
using a Molecular Imager Gel Doc XR System. 
 
2.3.4 TEM 
     Transmission electron microscopy (TEM) was used to examine the morphology of 
the Hb-PAA conjugate, Hb and PAA mixture (Hb/PAA), Hb and PAA. The images were 
obtained with a Tecnai T12 instrument operating at an accelerating voltage of 120 kV. 
Solutions of Hb-PAA, Hb/PAA and PAA were diluted to 0.1 mg/mL based on PAA 
concentration. The Hb solution was diluted to 0.1 mg/mL Hb. A drop of each solution 
was deposited on a copper grid covered with Fomvar film. Excess solution was blotted 
away with a piece of filter paper to leave a thin layer of solution on the grid. The sample 
was left to dry in air, and then stained with ruthenium tetroxide for 30 min. Digital 
images were collected and presented as is. 
 
 2.3.5 CD Spectra. 
          Far UV spectra of unmodified Hb, Hb-PAA and Hb/PAA were recorded using 
Jasco 710 spectropolarimeter. Each sample (2 µM) was in K2HPO4 (10 mM) pH 7.2 
buffer and the buffer spectrum was subtracted during processing. Step resolution was 
kept at 0.2 nm/data point and bandwidth and sensitivity were 1 nm and 20 millidegrees, 
respectively. Each protein sample was scanned from 190 nm to 260 nm and scan speed 
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was maintained at 50 nm/min. Average of four accumulations was recorded using 0.05 
cm pathlength cuvette.  Each sample was scanned from 350 to 450 nm and the scan 
speed was 50 nm/min. Pathlength used was 1 cm and eight accumulations were averaged 
to get each spectrum. These same parameters were also used to record far UV CD 
spectra, except for shorter pathlengths or lower protein concentrations, as stated in 
specific cases. 
 
2.3.6 Catalytic Activity Measurements.  
Peroxidase-like activity of Hb was used to compare the activity of Hb-PAA, Hb/PAA 
and Hb. Substrate, O-methoxyphenol (2.5 mM) and the oxidant, H2O2 (1 mM) were 
added to the protein solution (0.5 µM Hb in K2HPO4 (10 mM) pH 7.2 buffer). Oxidized 
product formation was observed by measuring the absorbance at 470 nm as a function of 
time in the kinetics mode, using HP 8453 diode array spectrophotometer.70 From the 
plot of absorbance vs. time, initial activities and specific activities were calculated and 
the values of Hb, Hb-PAA and Hb/PAA compared.  
 
2.3.7 Redox Activities.  
         Redox activity of Hb was tested by using sodium dithionite for the reduction of 
Fe(III) to Fe(II) and sodium ferricyanide to oxidize Fe(II) to Fe(III). Sodium dithionate 
was added to solutions of Hb (1 µM) and Hb-PAA (1 µM) and the absorbance spectra 
recorded. Similarly, the oxidation of Fe(II) to Fe(III) was monitored by recording the 
Soret absorbance after the addition of sodium ferricyanide (20 µM). The spectra of the 
untreated, reduced and the oxidized samples were scaled, corrected for the dilutions and 
overlaid for comparison. 
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2.3.8 Differential Scanning Calorimetry.  
DSC thermograms were recorded using a 6100 Nano II differential scanning calorimeter 
(Calorimetry Sciences Corporation, CSC Utah) by following a previously reported 
method from this laboratory71 All samples were degassed at least for 5 min prior to 
loading into the calorimeter, and cells were filled without air bubbles. Constant pressure 
of 3 atm was applied to the calorimeter to prevent solvent evaporation during the 
thermal scan. During buffer versus buffer scan, both cells were loaded with buffer (10 
mM K2HPO4 pH 7.2), equilibrated for 10 min at 20°C and scanned from 20 to 100°C at 
a scan rate of 2°C/ min. Once both heating and cooling scans were completed for buffer 
versus buffer system, the sample cell was emptied, washed and filled with the desired 
protein solution (4 µM Hb). Heating and cooling scans were recorded using parameters 
that were previously used with buffer versus buffer scan. The nanocalorimeter was 
interfaced to a personal computer (IBM compatible) and during data processing, 
background scan or the buffer vs. buffer scan was subtracted from the sample scan. Each 
scan was normalized with respect to hemoglobin concentration in the sample. A second 
heating cycle of the sample was used to check for reversibility of the thermal 
denaturation. Model independent parameters, such as peak transition temperature (Tm) 
and ΔHdenaturation (area under the curve) were calculated for each sample. 
 
2.3.9 Steam Sterilization Studies.  
      Solutions of Hb, Hb-PAA and Hb/PAA were autoclaved using SI-120 scientific 
isothermal sterilizer (Steric corporation, PA). Samples were heated to 120°C at 15 psi 
for 45 min in the sterilizer and cooled down to room temperature for 1 h. Activity 
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studies and CD studies were carried out with the samples at room temperature, using the 
above-mentioned procedures. 
 
2.3.10 Shelf-life Studies.  
    Storage stabilities of Hb, Hb-PAA and Hb/PAA were measured by monitoring the 
peroxidase-like activity of the heme protein as a function of storage at room 
temperature. Samples were withdrawn periodically, and activities have been measured 
using the procedure described above. Specific activities of samples were calculated, data 
normalized with respect to their corresponding initial activities, and relative specific 
activities thus obtained have been plotted as a function of storage time.    
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2.4 Results 
  
2.4.1 Conjugate design and synthesis.  
         The covalent attachment of PAA to Hb was carried out at pH 7.4, and at this pH 
the polymer was known to exist in an extended conformation due to its ionized carboxyl 
groups72 The reaction contained 0.2 % wt PAA and remained homogenous during 
synthesis. Conjugation of the protein to the polymer was confirmed by dialysis studies. 
The dialysate was monitored for Hb by monitoring absorbance due to the Soret band at 
406 nm, which showed no release of Hb from Hb-PAA reaction mixture. Hb-PAA 
samples, thus purified by dialysis, were investigated by UV-Vis spectroscopy by 
monitoring the heme Soret band (Figure 2.1). The Soret band of unmodified Hb 
indicated a peak maximum at 406 nm (Figure 2.1, blue line), which overlapped well 
with the Soret band of Hb-PAA conjugate (Figure 2.1, red line). The absorption 
spectrum of the physical mixture of Hb/PAA (same concentrations as above, Figure 2.1, 
406 nm λ max, green line), indicated a small decrease in intensity. The important 
observation is that both the peak position as well as the extinction coefficients of Hb and 
Hb-PAA at 406 nm are identical and the data suggests that the heme environment is not 
influenced by the covalent conjugation of lysine side chains of Hb with the carboxyl 
groups of PAA. Gel electrophoresis was also used to confirm attachment of Hb to PAA. 
Distinct differences in the net charge and mobilities of Hb, Hb-PAA and Hb/PAA are 
clearly visible in the gel (Figure 2.2). Hb and Hb/PAA both showed bands moving 
towards the cathode while Hb-PAA, which is highly negatively charged at pH 6.5, 
moved towards the anode.  
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Figure 2.1 Absorption spectra of Hb, Hb-PAA and Hb/PAA (1 µM protein) 
recorded in phosphate buffer (10 mM K2 HPO4 pH 7.2, 1 cm pathlength).   The 
Soret bands of Hb (blue line) and Hb-PAA (red line) are nearly superimposable 
while that of Hb/PAA mixture (green line) indicated minor decrease in Soret 
band intensity. 
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Figure 2.2 Gel electrophoresis image of agarose gel run at pH 6.5 tris acetate 
buffer, Hb-PAA conjugate (1), Hb/PAA mixture (2) and Hb (3).  
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2.4.2 Conjugate morphology.   
        The TEM image of Hb-PAA conjugate showed a porous network structure and not 
spherical particles (Figure 2.3a). The formation of fibrous network structure indicates 
that Hb and PAA are cross-linked randomly. Visible precipitate formation or 
flocculation is not observed and therefore a lightly cross-linked homogeneous solvent 
swollen network is proposed. As expected, the RuO4 did not preferentially stain either 
PAA or Hb but stained the conjugate as a whole (Figure 2.3a). The TEM of Hb/PAA 
also showed fibrous structure (Figure 2.3b) while the TEM image of Hb showed large 
spherical aggregates as well as smaller particles.  PAA at pH 7 showed the formation of 
spherical aggregates (Figure 2.3c and 2.3d, respectively).  
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Figure 2.3 TEM images of (a) Hb-PAA (0.2 wt% PAA) (b) Hb/PAA (0.2 wt% 
PAA) (c) Hb and (d) PAA (0.2 wt% PAA), stained by RuO4.  
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2.4.3 CD Spectra.  
     Changes in protein secondary structure due to covalent conjugation were 
assessed by comparing the UV-CD spectra of the conjugate with that of the unmodified 
Hb (Figure 2.4a). The UV-CD spectra are highly sensitive to the changes in protein 
secondary structure and they serve as excellent probes to examine protein structure73. 
The CD spectrum of unmodified Hb indicated a strong maximum at 190 nm and double 
minima at 208 nm and 222 nm (Figure 2.4a, blue line) and this is nearly the same as 
that of the Hb-PAA (Figure 2.4a, red line), recorded under the same conditions of 
buffer, concentration and pathlength74. The UV-CD of Hb/PAA (Figure 2.4a, green 
line), recorded under the same conditions as above, also indicated CD spectrum that is 
similar to that of the native Hb.  In light of only minor differences noted between the 
spectrum of the conjugate and that of Hb, we conclude that the secondary structure of 
the protein has been retained to a large extent.  
 The Soret CD of the Hb-PAA conjugate, which is a sensitive measure of the asymmetry 
of the heme environment in hemoglobin, was also examined (Figure 2.4b) to evaluate 
the changes in the heme environment, if any.  The Soret CD spectra of Hb (blue line) 
and Hb-PAA (red line) are similar, as in the case of the UV CD spectra, and the peak 
positions remained unchanged, which implies that heme coordination environment in the 
conjugate is well preserved and very similar to that of the unmodified Hb. The physical 
mixture of Hb and PAA indicated a minor decrease in the intensity of the Soret CD but 
not substantially different from that of the Hb. Encouraged by these CD data, we tested 
the redox activity of the heme prosthetic group in Hb-PAA. Retention of the redox 
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activity would be essential for biological or sensor applications of the protein-polymer 
conjugates. 
 
 
a  
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b 
 
Figure 2.4. Far UV CD spectra (Figure 2.4a) of unmodified Hb (black line) and 
Hb-PAA conjugate (red line), as well as those of a physical mixture of Hb and 
PAA (green line). All three samples contained same amount of Hb (4 µM protein 
in 10 mM K2HPO4 pH 7.2 buffer). Soret CD (Figure 2.4b) of Hb and Hb-PAA 
(4 µM protein in 10 mM K2HPO4 pH 7.2 buffer). Soret CD peak position of the 
conjugate is the same as that of Hb.  
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2.4.4 Redox Activity of Hb-PAA.  
             The Fe(III) center in met-hemoglobin undergoes efficient redox chemistry. 
Maintaining the Hb Fe(II) state under physiological conditions is critical for its 
biological activity. The Fe(II) form of Hb, for example, is capable of binding dioxygen 
while the Fe(III) form cannot, and therefore, the production of Fe(II) form of Hb-PAA is 
essential for practical applications. Addition of sodium dithionite reduces the Fe(III) 
form of Hb to the Fe(II) form, and the Soret band shifts concomitantly to the red.75 If the 
reduction is reversible, then the addition of sodium ferricyanide to the Fe(II) form of Hb 
reverts the heme to the Fe(III) state with a concomitant blue shift of the Soret band back 
to 406 nm.75 Therefore, we examined the redox activities of Hb and Hb-PAA (Figure 
2.5).  Reduction of the Fe(III) form of Hb (red line) to the corresponding Fe(II) form 
(green line) by the addition of dithionite resulted in a small red shift in the Soret band 
while the addition of ferricyanide to the Fe(II) form indicated the reversal of the Soret 
position to its initial position (blue line).  Similarly, the addition of dithionite to Hb-PAA 
(Figure 2.5b) indicated a large red shift (green line) while the addition of ferricyanide to 
the Fe(II) form reverted the peak back to 406 nm (blue dashed line).  The Fe(II) form of 
Hb-PAA showed a larger red shift than Hb and reasons for this are not immediately 
clear, but the spectral data clearly show that the Fe(III) form of the conjugate is reduced 
by dithionite, reversibly, and ferricyanide is capable of oxidizing the Fe(II) form of the 
conjugate.  Thus, Hb-PAA retained its redox activity, and covalent conjugation with the 
polymer did not inhibit this key property of Hb. 
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Figure 2.5. Redox activities of Hb (Figure 2.5a) and Hb-PAA conjugate 
(Figure 2.5b) (1 µM protein in 10 mM K2HPO4 pH 7.2 buffer) as indicated by 
the Soret absorption bands, upon the addition of sodium dithionite and sodium 
ferricyanide (20 µM). Redox activity of the heme moiety is retained in Hb-PAA 
conjugate.   
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2.4.5 Peroxidase-like Activity of Hb-PAA Conjugate.  
 
    Although Hb is not an enzyme, Hb can catalyze the oxidation of lipids and phenolic 
derivatives while using H2O2 as the oxidant.  Oxidation of 2-methoxyphenol, for 
example, by Hb in the presence of H2O2 produces a deep purple color due to the 
formation of dimeric and higher aggregates of the phenol which has an absorption 
maximum at 470 nm.76 The catalytic activities of Hb-PAA, Hb/PAA and Hb, under the 
same conditions of concentration, buffer, pH, and temperature, are compared in Figure 
2.6. The addition of H2O2 to the mixture of the biocatalyst and 2-methoxyphenol 
immediately produced the colored product, and increase in absorbance at 470 nm was 
monitored as a function of time (Figure 2.6).  The catalytic activity of Hb-PAA (red 
line) is nearly the same as that of Hb (blue line) and Hb/PAA (green line).  
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Figure 2.6 The peroxidase-like activity of Hb, Hb-PAA and Hb/PAA (1 µM 
protein) by the addition of 2-methoxyphenol (2.5 mM) and H2O2 (1 mM) as 
monitored by following the absorbance of the product at 470 nm (10 mM 
K2HPO4 pH 7.2 buffer at room temperature). Activity of Hb-PAA (red line) is 
almost the same as that of Hb (blue line) or Hb/PAA mixture (green line). 
Activities were normalized to the concentration of Hb in each sample. 
Conjugation of the polymer with the protein did not alter Hb activity.  
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2.4.6 Differential Scanning Calorimetry. 
          The influence of polymer conjugation on protein stability was evaluated by 
recording the DSC thermograms of Hb, Hb-PAA and Hb/PAA (Figure 2.7). The 
thermograms show that the conjugate (red line) begins to denature at 40˚C with a peak 
maximum of 65˚C and continues to denature up to 105˚C. This can be compared to Hb, 
which denatures over the range of 50-70˚C.  The Hb/PAA mix shows a peak, which is 
much broader and centered around 65˚C (Table 2.1). The integrated area under the 
curve is the corresponding enthalpy of denaturation and there was a significant 
difference in the enthalpy values obtained for Hb, Hb-PAA and Hb/PAA (Table 2.1). 
Hb and PAA had denaturation enthalpies of 90 and 760 kcal/mol, respectively. The Hb-
PAA conjugate, on the other hand, showed a significantly higher ∆H (1558 kcal/mol), 
which is greater than that of Hb/PAA (399 kcal/mol). The value is higher than the sum 
of the enthalpies of Hb and PAA by ~700 kcal/mol.  Such a substantial increase in the 
denaturation enthalpy is a welcome change and can be exploited to improve the thermal 
stability of the polymer conjugate.  Hence, the storage stability of the conjugate, at room 
temperature, is expected to be significantly better than that of the parent Hb.  First, we 
examined the stability of the protein-polymer conjugate toward sterilization with steam, 
which is a simple and efficient way to sanitize biomaterials for practical applications.77 
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Figure 2.7 The DSC thermograms of Hb, PAA, Hb-PAA and Hb/PAA. The 
molar heat capacity profiles of Hb (8 µM protein, blue line), PAA (4.4 µM, 
black line), Hb/PAA (8 µM protein, 4.4 µM PAA, green line), and Hb-PAA (8 
µM protein, 4.4 µM PAA, red line) recorded in 10 mM K2HPO4 pH 7.2 buffer at 
a scan rate of 2 ˚C /min.  The quantitative values of the corresponding 
thermodynamic parameters are listed in Table 1. 
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Table 2.1 Denaturation temperatures and ∆H values for Hb, Hb-PAA, Hb/PAA and 
PAA in 10 mM K2HPO4 pH 7.2 buffer, at a scan rate of 2 ˚C /min.  
 
   
Sample ΔH /kcal/mol Tm/ ˚C 
Hemoglobin 90 65 
Hb-PAA conjugate 1559 65 
Hb/PAA mix 399 65 
PAA 760 79 
 
 
2.4.7 Steam sterilization data.  
         The effect of high temperature sterilization of the conjugate on its structure and 
biological activity was investigated by subjecting the samples to steam sterilization. The 
ability to sterilize a material can influence its potential use as a biomaterial. Samples of 
Hb, Hb-PAA and Hb/PAA were heated to 120˚C at 15 psi, for 45 min.  After cooling the 
sample to room temperature, the peroxidase-like activity of each sample has been 
monitored, as described earlier. The activities of all of the samples decreased after steam 
sterilization, which is a commonly observed trend.78 The data shows that the decrease in 
activity is consistent for all three samples (Figure 2.8). 
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Figure 2.8 Peroxidase activities after steam sterilization and cooling to room 
temperature. Activities were measured with with1 mM H2O2 and 2.5 mM 2-
methoxyphenol in 10 mM K2HPO4  pH 7.2 buffer, at room temperature. The data 
has been normalized to the concentration of Hb in each sample. Activity of Hb-
PAA (broken red line) after steam sterilization is similar to the activities of Hb 
(broken blue line) and Hb/PAA (broken green line). There are no measureable 
differences among the three samples.  
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2.4.8 pH responsiveness.  
       The conjugation of PAA to Hb is expected to enhance the pH-responsiveness and 
Hb-PAA presented an excellent opportunity to test this hypothesis.  The effect of pH 
was investigated by monitoring the Soret peak as a function of pH (Figure 2.9, blue 
line, pH 7 to 11).  As the pH was raised from pH 8.1 to 9.5, the Soret peak of Hb-PAA 
shifted from 406 to 410 nm. Upon lowering the pH by the addition of acid, the Soret 
peak shifted back to 406 nm, and the two curves showed significant overlap with a good 
degree of reversibility.  The reversibility of this transition was compared to that of Hb.79 
The two transitions look very similar but that of the Hb-PAA appears in a narrower 
range of pH when compared to that of Hb.  This decrease in the pH range, and the 
resulting sharpening of the response, is likely due to the polymer network binding the 
subunits of Hb together.  Thus far, the conjugate indicated properties that are very 
similar to that of the parent Hb and only minor improvements are noted with the 
conjugate, if any.    
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Figure 2.9. The effect of pH on heme Soret peak from pH 7 to 11, (Hb (blue 
line) Hb-PAA (red line), 4.4µM PAA, 8µM Hb in PBS pH 7.4 buffer at 25°C). 
The peak shifted from 406 nm to higher values upon addition of NaOH and the 
transition was reversible with little or no hysteresis.   
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2.4.9 Shelf Life.  
                  Since proteins are designed to function in the well-controlled biological 
environment, solution stability of a protein rapidly decreases over time when stored at 
room temperature. Current state-of-the-art biocatalysts for large scale applications do 
not retain their catalytic activity at room temperature over extended periods of time, and 
this is a major barrier for practical applications in biocatalysis, biosensor fabrication or 
for use as biomaterials. Bioconjugation of enzymes is a known method to improve its 
room temperature stability or shelf life.80 To test, if conjugation of Hb to PAA improved 
its shelf life, specific activities of Hb, Hb-PAA and Hb/PAA samples that were stored at 
room temperature, have been measured as a function of time (Figure 2.10). This 
investigation successfully showed that PAA acts as a protection shell for Hb while 
allowing for the retention of catalytic activity. Hb-PAA and Hb/PAA retained 90% of 
their initial activities even after room temperature storage for 120 h. Activity of native 
Hb decreased rapidly, compared to conjugate and the physical mixture, and after 120 h 
of storage only 60% of activity was retained.  The study implies that conjugation or 
addition of PAA improves the retention of catalytic efficiency of protein over time 
allowing for proteins or enzymes to be stored at room temperature for long periods of 
time with little or virtually no loss in activity.                     
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Figure 2.10 Change in specific activity of the Hb-PAA as a function of time. 
Specific activities of Hb (blue line), Hb/PAA mix (green line) and Hb-PAA 
conjugate (red line) are compared, as a function of time. 1 mM H2O2 and 2.5 
mM 2-methoxyphenol in 10 mM K2HPO4 pH 7.2 were used to measure the 
peroxidase-like activities of the samples. Specific activity at time t was divided 
by specific activity at time 0 to compare the three sets of data.  
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2.5 Discussion 
Our synthesis of the Hb-PAA conjugate was quick, facile, efficient, and scalable. 
PAA of high molecular weight was the polymer of choice due to its large number of 
attachment points (COOH), mechanical characteristics, decreased cytotoxicity and 
scaffold potential.41,81,82 The use of carbodiimide coupling in phosphate buffer allowed 
for complete conjugation of hemoglobin to PAA. The complete attachment was 
confirmed by the absence of the release of Hb from Hb-PAA in dialysis studies, and 
from the absence of free Hb in gel electrophoresis studies. The Hb-PAA conjugate, 
though lightly cross-linked, remains homogenously dispersed in solution, and this 
feature makes the solution-based characterization of this conjugate possible. 
 
Table 2.2 Viscosities at a shear rate of 1.0 (1/s) for 0.2 wt% PAA and Hb-PAA in PBS. 
The PAA concentration is 0.2 wt% is the Hb-PAA sample. 
 
Sample Viscosity (Pa s) 
PAA 450k 7.82 x 10-3 
Hb-PAA 0.023 
 
 
The TEM and viscosity (Table 2.2) aided in confirming the prescence of a lightly 
cross-linked network. The extensive characterization of the conjugate showed that 
despite multiple covalent attachments to Hb, there is no significant difference in heme 
environment, helical content and peroxidase-like activity of the conjugate in comparison 
to the unmodified Hb. The activity of Hb-PAA was found to be slightly higher than that 
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of Hb and Hb/PAA. The retention of structure protein structure was further confirmed 
by the reversibility of the Soret peak characteristics upon reduction and oxidation of the 
iron center.  The thermal denaturation of Hb occurs at 64.9°C, and this value is very 
close to that of the Hb-PAA conjugate, although the range of denaturation and enthalpy 
value was significantly increased. The conjugation of Hb to PAA leads to an increase in 
ΔHdenaturation of ~700 kcal/mol. The increase in denaturation enthalpy implies an increase 
in thermal stability of conjugate over unmodified Hb and Hb/PAA mixture. Steam 
sterilization followed by activity measurements show that the conjugate retained only a 
slightly higher percent activity compared to Hb and Hb/PAA. In contrast to thermal 
denaturation, the pH-induced denaturation was shown to be completely reversible for the 
conjugate as well as the free Hb but the denaturation of the conjugate occurred over a 
narrower pH range than that of Hb. Investigations into the room temperature stability 
showed interesting results.  
          The shelf life of Hb-PAA was investigated by monitoring the activity of the 
conjugate after storing the samples at room temperature for increased lengths of time. 
This study conducted over a period of 120 h showed a dramatic loss in activity of Hb 
(<60%). After just 20 h, Hb activity dropped by 25% while Hb-PAA showed no 
apparent decrease. Hb-PAA did show a loss of less than 10% after 120 h storage at room 
temperature, while that of Hb dropped by >40%. This dramatic retention of activity of 
the conjugate can be attributed to the presence of PAA chains that prevent the protein 
from denaturation, followed by aggregation. There was no visible aggregation observed 
in the Hb-PAA solution , which was not the case for Hb solution. 
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Scheme 2.1 Proposed Hb-PAA network structure. Black lines represent the 
PAA chains with Hb (blue and red objects) covalently attached. The cartoon on 
the left shows the sample at room temperature with Hb in its native state, and 
the one on the right represents the conjugate above the denaturation temperature 
of Hb. The double-headed arrow represents reversibility of this transition under 
thermal or pH cycling.    
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       The protein-polymer material we have presented here, Hb-PAA, has properties and 
characteristics that make it a good candidate for biomedical and sensing applications82. 
Most of the investigations of Hb conjugates have been targeted towards improving in 
vivo circulation times and oxygen binding capacity for applications as blood 
substitutes.83,84 However, to exploit unique properties of Hb conjugates in other 
applications, it is imperative to design methods to protect the 3D structure of Hb and to 
investigate its catalytic efficiency and shelf life when stored under ambient conditions. 
Our ability to prepare Hb-PAA conjugates that remain solvent-swollen can be exploited 
to cast films, which  retain catalytic efficiency and prolonged shelf life, and they would 
be extremely important for sensing applications. Covalent conjugation is preferred over 
physical interaction-based systems because the covalent bonding would prevent protein 
or catalyst from leaching out of the conjugate, thereby resulting in lowered catalytic 
activity. Another advantage of our system is that by attaching high-molecular-weight 
polymer to a protein, the processability and range of physical properties of the protein as 
a material is broadened significantly. The Hb-polymer conjugate system, demonstrated 
here, may be expanded to investigate the effect of other biocompatible or biodegradable 
polymers as well as other proteins or enzymes. 
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2.6 Conclusion 
Here, we have shown that Hb can be covalently attached to polyacrylic acid 
without having any significant detriment to the structure and activity of the protein.  The 
heme environment remains unaffected by the multiple PAA attachment points as shown 
by Soret absorption, peroxidase-like activity and redox activity. Thermal studies showed 
that the conjugation significantly increased the denaturation enthalpy. The room 
temperature stability of the solution was the most noteworthy result of this study. The 
stability of the protein in solution was extensively increased due to the covalent 
attachment of PAA chains.  This work has demonstrated a facile approach to improving 
Hb stability, and our approach can be further expanded for use with other proteins or 
polymers.  
 
Reprinted (adapted) with permission from Thilakarathne,V.; Briand, V.A.; Zhou,Y.; 
Kasi, R.M; Kumar, C.V. Protein Polymer Conjugates: Improving the stability of 
Hemoglobin with Poly(acrylic acid). Langmuir 2011, 27, 7663-7671. 
             Copyright (2011) American Chemical Society. 
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Chapter 3 : Tuning protein/polymer interaction by controlled chemical 
modification 
3.1 Abstract 
Protein-polymer interactions play a very important role in a number of applications, but 
details of these interactions are not fully understood.  Chemical modification was 
introduced here to tune protein-polymer interactions in a systematic manner, where met-
hemoglobin (Hb) and poly(acrylic acid) (PAA) served as a model system.  Under similar 
conditions of pH and ionic strength, the influence of protein charge on Hb/PAA 
interaction was studied using chemically modified Hb by isothermal titration calorimetry 
(ITC). A small fraction of COOH groups of Hb was amidated with triethylenetetraamine 
(TETA) or ammonium chloride to produce the corresponding charge ladders of Hb-
TETA and Hb-Ammonia derivatives, respectively. All the Hb/PAA complexes produced 
here are bioactive, entirely soluble in water, and indicated the retention of Hb structure 
to a significant extent.  Binding of Hb to PAA was exothermic (∆H<0) and Hb-TETA 
charge ladder indicated decrease of ∆H from -8+0.2 to -89+4 kcal/mol, at a rate of -3.8 
kcal/mol per unit charge introduced via modification. Hb-Ammonia charge ladder, in 
contrast, decrease of ∆H from -8+0.2 to -17+1.5 kcal/mol, at much slower rate of -1.0 
kcal/mol per unit charge.  Thus, the amine used for the modification played a strong role 
in tuning Hb/PAA interactions, even after correcting for the charge, synergistically.  
Charge clustering may be responsible for this synergy and this interesting observation 
may be exploited to construct protein/polymer platforms for advanced 
biomacromolecular applications. 
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3.2 Introduction 
          Controlling protein/polymer interactions is vital for the construction of protein-
polymer hybrid scaffolding platforms for biocatalytic, biosensing and biomedical 
applications. Many of the protein/polymer platforms use protein immobilization with 
polymers via layer-by-layer method85,86,87,88 covalent bonding, precipitation89,90,91,92 or 
encapsulation.93,94,95 
          Protein-polymer interactions, for example, are important in the development of 
biocompatible, stable, inexpensive and sterile drug delivery systems.96 Biotherapeutics 
such as peptides, proteins and nucleic acids are susceptible to degradation or 
denaturation in the biological milieu,97 and polymeric multilayer capsules have been 
used to protect these sensitive biologics.98,99,100 Vast numbers of multilayer assemblies 
were fabricated by alternative deposition of oppositely charged polymers, where the 
polymer-protein interactions play crucial roles in the assembly formation and 
stability.101 On a similar account, polyelectrolyte based microgels, hydrogels and 
interpenetrating polymer networks allowed uptake and delivery of biotheraputics.102,103 
               Molecular interactions play a significant role in the design and construction of 
these platforms, and understanding the contributions of specific molecular segments to 
these interactions can facilitate better design of materials for the above applications.104 
Our understanding of molecular signatures and thermodynamics of the protein/polymer 
interactions are rudimentary, despite several important studies.105,106,107,108,109 The goal 
of the present work is to perturb the protein-polymer interactions precisely and gain 
insight into the details of these interactions by ITC studies. Very few thermodynamic 
studies provide a detailed analysis of contributions of each interactive force toward 
protein/polymer complex formation.110 This gap in knowledge is because of the 
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complexity of separating these interactions and limited availability of rational 
approaches to control them in a predictable manner. 
        Use of different proteins to factor out specific contributions to these interactions, 
for example, would make the study complicated since each protein has its own structure 
with different kinds of amino acid residues decorating its surface.  These amino acid 
residues play a major role in defining the hydrophobic and charged patches on the 
protein surfaces.111 As a step forward, in this paper, we introduce protein chemical 
modification as a rational route to introduce specific interactions at the protein-polymer 
interface and study their influence quantitatively. Chemical modification is a powerful 
tool to introduce specific molecular segments on protein surfaces,112 but it has not been 
used to control protein/polymer interactions in a systematic manner.  This latter outcome 
could be quite useful in the design of novel functional biomacromolecules with defined, 
predictable properties.    
 Earlier studies from our group showed that protein charge plays a significant role in 
defining the protein/solid interactions and we hypothesized that protein charge controls 
the binding enthalpies in a predictable manner.113,114 Along these lines, we now test the 
hypothesis that binding of proteins to charged polymer molecules (polyions) would also 
depend on protein charge and that chemical modification of the protein can serve as a 
predictable tool to probe these interactions  in a systematic manner by calorimetric 
methods. Poly(acrylic acid) (PAA), a water-soluble, negatively charged, polymer and 
met-hemoglobin (Hb) have been chosen as a model system. Previously, cross-linking of 
Hb with PAA was shown not to perturb Hb structure or it’s peroxidase-like activity.115 
Surprisingly, PAA conjugation improved Hb shelf life.  Therefore, understanding the 
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nature of Hb/PAA interactions will be interesting, and it may provide rational 
approaches to produce functional biomacromolecules with predictable properties.  
 Hb is negatively charged at pH 7, and its charge can be tuned by converting the 
carboxyl functions of aspartic and glutamic acid side chains to their corresponding 
amides.  Replacing the negatively charged amino acid side chains, for example, with 
neutral or positively charged ones alters protein charge in a predictable manner. Control 
of Hb charge by chemical modification provided a simple method to gain further insight 
into Hb/PAA interactions. 
 The carboxyl groups of Hb, in the current study, are amidated with ammonia or 
triethylenetetramine (TETA) to produce the corresponding charge ladders.  The extent of 
amidation, protein/polymer concentrations, ionic strength and pH are adjusted such that 
only soluble Hb/PAA complexes are produced.116,117 This aspect is important because 
precipitation or insoluble complex formation introduces complications.  Data show that 
the complex formation is exothermic and exothermicity increases with increasing 
protein charge. More interestingly ITC studies indicated that Hb-TETA/PAA interaction 
is much more enthalpically favorable than Hb-Ammonia/PAA interaction, even after 
correcting for the charge. This increase is over above that due to the binding of TETA 
itself to PAA, and thus, a strong synergistic effect has been established where the TETA 
s egment enhanced the binding enthalpies by anew mechanism. 
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3.3 Experimental methods 
 
3.3.1 Materials:  
       Bovine met-hemoglobin (Hb), polyacrylic acid (PAA, 450, 000 MW), 1-ethyl-3-(3-
dimethyl aminopropyl) carbodiimide hydrochloride (EDC), triethylenetetraamine 
(TETA), NH4Cl,  N-hydroxysuccinimide (NHS), ethanolamine and 2-methoxyphenol 
were purchased from Sigma Aldrich (St. Louis, MO). β-mercaptoethylamine 
hydrochloride was obtained from Fisher and used as received. Phosphate buffered saline 
(PBS, 10 mM phosphate 0.137 M NaCl) at pH 7.4 and 6.4 were used to prepare the 
solutions.  
 
3.3.2 Isothermal titration calorimetry (ITC): 
          Energetics associated with Hb binding to PAA were measured using a 
nanocalorimeter (VP-ITC from Microcal Inc. Piscataway, NJ). PAA (450,000 MW) 
solution was prepared by dissolving 0.3 mg/ml or 0.03 wt% of PAA (0.7 µM) in 
distilled water and pH adjusted to 7.4.  Hb (486 µM in PBS) and PAA samples were 
dialyzed against PBS pH 7.4 or PBS pH 6.4.  Calorimeter was thermally equilibrated for 
one hour and dialyzed PAA was loaded into the calorimetric cell (1.4167 ml) while Hb 
solution has been loaded into the automated syringe. During the experiment, 6 µl 
aliquots of Hb solution were added in successive injections to PAA solution (0.7 µM) 
with 300 s intervals, and heat absorbed or released with each injection has been 
recorded.  
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 The heats of dilution of the protein and the polymer were measured separately and 
subtracted from the titration data, analyzed by Origin software (v. 5.0, Microcal Inc., 
Piscataway, NJ). The heat released or absorbed (Q) during the titration is related to the 
molar heat of protein binding (ΔH), the volume of the sample cell (Vo), the initial 
concentration of the ligand (Xt), PAA concentration (Mt), the binding constant (Kb), and 
the number of binding sites (n) by equation 1.118,119  
     
 
The calorimetric data were fitted to a single set of non-interacting, identical binding sites 
model and Kb, n, ΔH and ΔS were extracted from best fits to the data to equation 1. The 
limitations of the above model to fully describe protein binding to various surfaces is 
well known, and hence, we proceeded to test the validity of the above binding enthalpies 
by using a direct method, described below. Each titration was performed three times and 
errors estimated from multiple measurements.  Fits to each curve were performed 
multiple times with different initial values of Kb, n and ΔH to find the best fit, and the 
values of ΔS and ΔG calculated, using standard equations of thermodynamics. 
 
3.3.3 Model independent method for the determination of binding enthalpies: Hb and 
PAA concentrations were adjusted such that when an aliquot of Hb solution was added 
to PAA solution, most of the protein binds to PAA to produce soluble protein/polymer 
complex.  Four successive additions of 60 µl Hb solution (4 mg/ml 60 µM, in PBS pH 
6.4) into the cell (PAA, 4 mg/ml in PBS pH 6.4) were done at intervals of 300 seconds 
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each.  The injections were separated by 48 seconds of mixing time, at a stirrer speed of 
300 rpm.  Heat released or absorbed during the reaction time was recorded and the data 
have been corrected for the corresponding dilutions of Hb and PAA solutions.  To factor 
out the enthalpy changes due to chemical modification, the binding enthalpies of TETA 
and NH4Cl ligands (no protein) with PAA were also measured.  Each measurement was 
repeated multiple times and the errors estimated from these. 
 
3.3.4 Dynamic light scattering (DLS):  
        Hydrodynamic radius of Hb/PAA and Hb-TETA/PAA soluble complexes were 
measured using CoolBatch+ dynamic light scattering apparatus, where a Precision 
detector (Varian Inc.,) using a 0.5 x 0.5 cm2 square cuvette and 658 nm excitation laser 
source at 90˚ geometry. Hb and Hb-TETA samples (60 µM) were diluted once and 
filtered with 0.2-micron filter (PVDF, 13 mm, Fisher Scientific) prior to the 
measurements. Hb/PAA and Hb-TETA/PAA, soluble complexes from the ITC chamber 
(8.7 µM protein and 7.7 µM PAA) were diluted 10x and filtered. All samples were 
equilibrated for 300 s  at 26 ˚C and 5 repetitions with 60 accumulations were done at the 
same temperature. Precision Elucidate Version 1.1.0.9 was used to run the experiment 
and Deconvolve Version 5.5 was used to process the data. 
 
3.3.5 Surface plasmon resonance studies for Hb binding to PAA:  
       Surface plasmon resonance (SPR) was performed using an SR7000DC dual channel 
flow SPR spectrometer from Reichert Analytical Instruments (Depew, NY) with a semi-
automatic injection setup with 500 µL PEEK injection loop and Harvard Apparatus flow 
pump.  The flow cell was setup with a Y-connector to facilitate parallel flow through the 
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sample and reference channels, at 25°C. The running buffer (PBS, 0.1M phosphate, 
0.1M NaCl, 2.7 mM KCl) was thoroughly degassed before use.  The data were analyzed 
using the Scrubber 2.0 software (BioLogic Software, Australia) and Kaleidagraph 
(Synergy Software, Reading PA).   
 
The bare gold chips were obtained from Reichert (catlog # 13206060) and 
functionalized with 100 mM β-mercaptoethylamine hydrochloride in ethanol/water 
(80/20 v/v) mixture (Scheme 3.1). The chip was immersed in the solution, purged with 
nitrogen gas, sealed and equilibrated overnight (12 h) followed by rinsing with ethanol 
and drying in nitrogen flow. The aminothiol self-assembled monolayer (SAM) covered 
Au chips were used immediately to avoid oxidation. 
              The functionalized Au chip was mounted in the Reichert SPR flow cell and 
PAA was attached to the amine SAM by carbodiimide coupling (Scheme 3.1). The 
carboxylic acid groups of PAA (13.9 mM COOH groups, 1 mg PAA/mL) were activated 
by flowing a mixture of EDC (100 mM) and NHS (40 mM) over the SAM for 2000 s at 
a flow rate of 20 µL/min. The functionalized PAA surface was rinsed by washing with 
PBS buffer (50 uL/min flow rate) until the baseline remained constant. Any remaining 
activated PAA COOH groups were blocked by reaction with ethanolamine (1 M). 
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Scheme 3.1. PAA immobilized on SPR Au chip with Hb injections to 
determine Hb/PAA physical interactions.  
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Hb solutions (1 to 25 µM, as needed) were flowed over the PAA-coated Au chip for 300 
s at a flow rate of 20 µL/min and the association/dissociation curves have been obtained 
in real time.  These kinetic curves were fit to obtain the corresponding ka and kd values 
by Scrubber.  The reference channel showed a significant amount of direct binding of 
Hb to the amine SAM and for this reason the reference curves were not subtracted from 
the corresponding sample channel curves.  To re-cycle the chip, Hb bound to PAA-SAM 
was removed by injection of NaOH solution (pH 12.5) to wash Hb from the PAA layer 
on the Au chip and the regenerated polymer surface indicated consistent binding of Hb 
to PAA during the second and subsequent cycles of Hb binding. Multiple regeneration 
cycles were used to examine the binding at increasing concentrations of Hb, at a 
constant loading of PAA on the Au chip.  Each measurement was repeated multiple 
times to obtain errors in the measurements. 
 
3.3.6 Chemical modification of hemoglobin:  
          Aspartic and glutamic acid residues of Hb were modified by activating them with 
carbodiimide and by reaction with either ammonium chloride or TETA, by adopting 
reported methods.120 Hb (4 mg/ml) dissolved in deionized water (DI) was stirred with 
the appropriate amine (pH adjusted to 5 or 7) for half an hour followed by the addition 
of EDC (10 mM).  The reaction mixture was stirred for additional 4 h at room 
temperature and unreacted EDC, amine and byproducts were removed by dialysis 
against PBS buffer at pH 6.4.  
 The degree of modification, and therefore the net charge on the modified Hb, 
was controlled by adjusting the pH (5 or 7) or amine concentration (40 mM to 2.5 M), at 
a constant reaction time (4 hours, Table 3.1). Chemically modified Hb samples are 
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labeled as Hb-TETA40-7, where the derivative has been obtained by reacting TETA (40 
mM) with Hb at pH 7. 
 
 
 
Table 3.1. Optimum conditions for the synthesis of Hb derivatives (4 h reaction time). 
Sample Initial [amine]  used 
for the reaction 
[EDC] pH of the 
reaction 
Hb - - - 
Hb-TETA40-7 40 mM TETA 10 mM 7 
Hb-TETA40-5 40 mM TETA 10 mM 5 
Hb-TETA80-5 80 mM TETA 10 mM 5 
Hb-TETA60-7 60 mM TETA 10 mM 7 
Hb-TETA60-5 60 mM TETA 10 mM 5 
Hb-NH3400-5 400 mM NH4Cl 10 mM 5 
Hb-NH3800-5 800 mM NH4Cl 10 mM 5 
Hb- NH31k-5 1 M NH4Cl 10 mM 5 
Hb-NH31.5k-5 1.5 M NH4Cl 10 mM 5 
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3.3.7 Agarose gel electrophoresis:  
    Agarose gel electrophoresis was performed using horizontal gel electrophoresis 
apparatus (Gibco model 200, Life Technologies Inc, MD) and agarose (0.5 % w/w) in 
Tris acetate (40 mM) buffer.  Modified Hb samples were loaded with 50% loading 
buffer (50% v/v glycerol and 0.01% w/w bromophenol blue). The running buffer was 
Tris acetate (40 mM) adjusted to specific pHs to determine the isoelectric points of the 
Hb-derivatives. Samples were spotted into wells placed at the middle of the gel, so that 
the protein could migrate towards the negative or the positive electrode, based on net 
charge. A potential of 100 V was applied for appropriate duration, gels were stained 
overnight with 10% v/v acetic acid, 0.02% w/w Coomassie blue, followed by destaining 
in 10% v/v acetic acid, overnight. 
 
3.3.8 Circular dichroism measurements:  
            Structural changes of Hb, if any, upon chemical modification, as well as after 
complexation with PAA, were monitored using circular dichroism studies. Far UV and 
soret CD spectra of unmodified Hb, TETA modified Hb and PAA/Hb mixtues were 
recorded using Jasco 710 spectropolarimeter. Same concentrations of Hb and PAA used 
for ITC experiments were also used to for CD studies. All samples were in PBS pH 6.4 
and the buffer scan was subtracted during processing. Step resolution was kept at 0.2 
nm/data point and bandwidth and sensitivity were 1 nm and 20 millidegrees, 
respectively. When collecting far UV CD spectra each  sample was scanned from 200 
nm to 260 nm and scan speed was maintained at 50 nm/min. Average of four 
accumulations was recorded using 0.05 cm pathlength cuvette.  For the soret CD spectra, 
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samples were scanned from 350 to 450 nm at a scan speed of 50 nm/min, 0,2 cm path 
length, and eight accumulations were averaged. 
 
3.3.9 Hemoglobin peroxidase-like activity studies:  
          Peroxidase-like activity of Hb was used to compare the activities of Hb in the 
presence and absence of PAA. The substrate, O-methoxyphenol (5 mM) and the oxidant, 
H2O2 (0.5 mM) were added to the solution containing 1 µM Hb in PBS, pH 6.4.  
Absorbance at 470 nm, due to the product formation, was monitored as a function of 
time, using HP 8453 diode array spectrophotometer (Agilent Inc., Totowa NJ).121 From 
the plots of absorbance vs. time, initial velocities and specific activities were calculated 
and the activities compared under the same conditions of pH, ionic strength, substrate 
concentration and temperature. 
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3.4 Results 
 The hypothesis that chemical modification of proteins serves as a convenient 
method to systematically modulate hemoglobin-PAA interactions has been tested here. 
Chemical modification with TETA, for example, served to probe the contributions of 
charge and TETA segments to these interactions which revealed strong synergy. 
 
3.4.1 Energetics of Hb binding to PAA:  
         Using Hb as a model protein and PAA as a model polymer, we examined the 
binding of Hb to PAA to form a soluble complex, under a specific set of conditions by 
isothermal titration calorimetry (ITC).  Exothermic binding of Hb to PAA, at pH 7.4 in 
PBS buffer, was demonstrated in Figure 3.1, and binding saturated at a Hb to PAA mole 
ratio of ~14.   
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A     
B    
Figure 3.1. Titration of Hb (486 µM) with PAA (0.7 µM) in PBS, pH 7.4 at 25 
˚C. (A) Change in power vs time plot when PAA solution was titrated with Hb 
solution. (B) Enthalpy change vs [Hb]/[PAA] for titration. Red line is the best fit 
to the data, according to the single, identical, non-interacting binding site model. 
Best fit indicated a binding stoichiometry of 14 Hb per mole of PAA, binding 
constant of 3.2x105 M-1, ∆H and ∆S values of -7.4 kcal/mol of Hb bound and 
0.1715 cal/mol, respectively. 
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         Enthalpy change associated with each addition of Hb solution to PAA solution was 
plotted as a function of the ratio of molar concentrations of Hb to PAA (Figure 3.1B, 
black dots), and the data were fitted to a single set of indistinguishable, non-interacting 
binding sites model (Figure 3.1B, red curve, using equation 1).  The best fit to the data 
indicated Kb, ∆G, ∆H, ∆S and the binding stoichiometry to be 3.2+0.75x105 M-1, -7.3± 
0.95 kcal/mol, -7.4±0.2 kcal/mol, 0.17 cal/mol and 14 Hb molecules bound per each 
PAA molecule, respectively. Hb binding to PAA is exothermic, with significant affinity, 
and large loading on the polymer of 14:1 protein to polymer (monomer) mole ratio, and 
the binding is primarily enthalpy driven (-7.4±0.2 kcal/mol) but it is also entropy 
favored.  The above single-site binding model assumes that there are no interactions 
between the bound protein molecules and that the binding sites on PAA are non-
overlapping.  Introduction of these assumptions simplifies data analysis but could 
introduce potential errors in the estimated parameters.122,123 Hence, we have used a 
model-independent method to measure binding enthalpies, directly, and compared them 
with these values, as described later.  The binding enthalpy determined above, is in good 
agreement with the values obtained from the direct measurement, described below. 
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3.4.2 SPR Studies:  
      Hb binding to PAA is also verified by SPR studies.   PAA was immobilized on Au 
chip using the amino-thiol SAM and EDC coupling ( Scheme 3.1), and from the SPR 
signal of 500 µRIU, and the conversion factor of one microRIU corresponds to 0,73 
ng/mm2 of mass,124 we estimate that 365 ng of PAA was attached to one square 
millimeter.  Using the known density of PAA,125 we estimate an average polymer layer 
thickness of 300 nm and this is a lower limit on the PAA film thickness, as the polymer 
can swell substantially due to hydration as well as the pH of the medium. PAA film was 
used to monitor Hb binding by SPR.  Flowing Hb solutions over the PAA surface in the 
sample channel resulted in huge SPR signal increases, while the reference channel 
indicated only weak signals.  We monitored the on- and off-rates of Hb binding to the 
PAA SAM (Figure 3.2) and best fits to the data indicated on- and off-rate constants of 
1.2x103 M-1s-1 and 2.8x10-3 M-1, respectively (5 µM, PBS, pH 7.2) to PAA film. The 
ratio of the on- to off-rate constants, the binding constant, is 7.1 x 105 M-1 and this value 
is comparable to that obtained from the ITC data, 3.2±0.7 x 105 M-1.  Therefore, the 
calorimetric and SPR measurements agree reasonably, and indicate substantial 
interaction of Hb with PAA but note that SPR cannot provide direct enthalpy 
measurements. 
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Figure 3.2.  Hb association dissociation curve for 10µM Hb binding to PAA in 
PBS pH 7.4 (500µRIU PAA immobilized). (black – Hb binding curve, red- data 
fit by Scrubber software) 
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3.4.3 Chemical Modification:  
      Several factors could contribute to the observed Hb and PAA interactions, and 
chemical modification is a convenient tool to evaluate specific contributions to these 
interactions. For example, the conversion of the COOH groups of the aspartate and 
glutamate residues of Hb to the corresponding amides would neutralize at least one 
negative charge per COOH modified (Scheme 3.2).  For example, amidation with TETA 
would lower the protein negative charge by the conversion of COOH groups to the 
corresponding amides, and additional charge neutralization can occur by the protonation 
of the basic nitrogens of TETA.  Thus, chemical modification provided an appealing 
method to continuously tune net charge of Hb at constant pH and ionic strength, in a 
systematic and predictable manner. 
              Hb was reacted with increasing concentrations of TETA or NH4Cl under 
specific conditions of pH, temperature, amine concentration and reaction time, using 
EDC chemistry (Scheme 3.2). Nine different Hb-TETA and Hb-Ammonia derivatives 
were prepared successfully, and they have been purified by extensive dialysis to remove 
unreacted reagents and by-products.  The progress of Hb modification has been 
monitored by agarose gel electrophoresis, described below.  
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Scheme 3.2 : Chemical modification of Hb COOH groups via EDC chemistry.  
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 3.4.4 Agarose gel electrophoresis:  
 Chemical modification altered the net charge on Hb, as monitored in agarose gels 
(Figure 3.3), and modified samples began to migrate toward the cathode. The samples 
were loaded into wells at the center of the gel, and Hb did not migrate out of the wells 
(lane 1, Figure 3.3).  The isoelectric point (pI) of Hb is ~6.77126 , at pH 7 Hb is nearly 
neutral, and hence, it did not move out of the well. As the extent of amidation increased 
with increasing TETA concentration, the net negative charge on the Hb-derivative 
decreased, or positive charge increased, and samples began to migrate towards the 
cathode (lanes 2-4, Figure 3.3).  All the Hb-TETA samples migrated toward the 
cathode, directly proving that they bear net positive charge.   Thus, Hb-TETA charge 
ladder consisting of Hb-TETA40-7, Hb-TETA40-5 and Hb-TETA80-5 are produced 
successfully.  
         The reaction of ammonia with Hb facilitated by EDC chemistry, under specific 
reaction conditions (Table 3.1), also resulted in a charge ladder of Hb-Ammonia 
derivatives (lanes 5-8).  Note that these samples, although migrated toward the cathode, 
better than Hb, bore less positive charge when compared to those of the Hb-TETA 
derivatives.  Nevertheless, Hb-Ammonia derivatives also indicated better mobilities than 
Hb. 
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Figure 3.3. Agarose gel electrophoresis of Hb-TETA and Hb-Ammonia derivatives at 
pH 7 (samples spotted at the center of the gel). Lane 1 is Hb and lanes 2-4 are Hb-
TETA40-7, Hb-TETA40-5 and Hb-TETA80-5, respectively, while lanes 5-8 are the Hb-
Ammonia derivatives, Hb-Ammonia400-5, Hb-Ammonia800-5, Hb-Ammonia1k-5, Hb-
Ammonia1.5k-5, respectively, produced under specific reaction conditions. 
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           The electrophoresis data are consistent with progressive conversion of Hb to Hb-
TETA or Hb-Ammonia derivatives with decreasing negative charge or increasing 
positive charge, as the case may be.  Thus, chemical modification has successfully 
produced two different charge ladders of Hb-derivatives where the protein charge was 
controlled in a gradual and systematic manner. 
 
3.4.5 Charge and isoelectric points of Hb charge ladders:  
        Since the mass difference between Hb and Hb-derivatives is negligible, migration 
distance of each band in the agarose gel is proportional to its charge.127 Therefore, 
agarose gels were run at specific pH values (Figure 3.4 & 3.5) and at each pH, certain 
samples migrated toward the positive or negative electrode. Using the known charge of 
Hb126 , charges of all Hb-derivatives were determined (Table 3.2 & 3.3).   
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Figure 3.4. Agarose gels of chemically modified hemoglobin derivatives at pH 
6, 8, and 9 (A through C respectively). Lane 1 in each gel is Hb and lanes 2, 3, 
& 4 are Hb-TETA40-7, Hb-TETA40-5 and Hb-TETA80-5 respectively. Lanes 
5-8 are Hb-NH4Cl400-5, Hb-NH4Cl800-5, Hb-NH4Cl1k-5, Hb-NH4Cl1.5k-5, 
respectively. Mid point of each protein band as indicated was taken as the 
distance migrated in the agarose gel. Distance and charge relationship of the 
modified Hb derivatives, relative to the distance and charge of Hb, were 
calculated using imageJ 1.46r software from NIH and tabulated in Table 3.2. 
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Figure 3.5. Agarose gels of chemically modified hemoglobin derivatives at pH 
6, 6.8, 7.5 and 8.7. Lane 1 in each gel is Hb and lanes 2, 3, 4, 5and 6 are Hb-
TETA40-7, Hb-TETA40-5 , Hb-TETA80-5, Hb-TETA60-7 and Hb-TETA60-7  
respectively. Mid point of the protein band in lane 5 and 6  was taken as the 
distance migrated in the agarose gel. Distance and charge relationship of the 
modified Hb derivatives, relative to the distance and charge of Hb, were 
calculated using imageJ 1.46r software from NIH and tabulated in Table 3.3. 
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Table 3.2  Average charge of modified Hb were calculated from the distance charge 
relationship relative to the unmodified Hb. 
 
Sample Average charge  
at pH 6 
Average charge  
at pH 8 
Average charge  
at pH 9 
Hb +10  - 10  -20  
Hb-TETA40-7 +15  -8.8  -15  
Hb-TETA40-5 +21.6  +6.46  -6.2  
Hb-TETA80-5 +26.6  +9.4  -3.1  
Hb-NH3400-5 +15  -8.2  -18.1  
Hb-NH3800-5 +15.4  -7.6  -16.9  
Hb-NH31k-5 +15.8  -5.9  -11.2  
Hb-NH31.5k-5 +18.3  +1.1  -8.1  
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Table 3.3  Average charge of modified Hb were calculated from the distance charge 
relationship relative to the unmodified Hb. 
 
 
Sample Average 
charge  
at pH 6 
Average 
charge  
at pH 6.8 
Average 
charge  
at pH 7.5 
Average 
charge  
at pH 8.7 
Hb-TETA60-7 +16.2 + 10 0 -12.6 
Hb-TETA60-5 +25  + 15 +8 0  
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            When pH of the running buffer is equal to the pI of the protein, net charge on the 
protein will be zero, and the sample will not move out of the loading well, under the 
influence of the applied electric field.  Therefore, charge obtained from the band 
mobility of each sample was plotted as a function of pH, and from these plots we 
obtained the pH at which the charge on the protein is zero (pI value) (Figure 3.6, Table 
3.4). The pI values of the samples, for example, increased from ~7 to ~9, with increased 
chemical modification, and chemical modification successfully resulted in the 
construction of Hb charge ladders. 
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Figure 3.6. Plot of pH vs charge of Hb and Hb-TETA and Hb-NH4Cl derivatives. 
Y Intercept of each curve was taken as the isoelectric point (pI). Charge of each 
derivative at pH 6.4 where ITC measurements were take were also extracted from 
the plot. 
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Table 3.4. Key properties of Hb-derivatives.  The isoelectric points (pI), average charge 
at pH 6.4, and binding enthalpies (kcal/mol), in PBS, pH 6.4, at 25 ˚C. 
 
Sample pI Charge at pH 6.4 ∆H (kcal/mol) 
Hb 7 +6 -8 ± 0.2 
Hb-TETA40-7 7.4 +10 ± 0.5 -45 ± 2 
Hb-TETA40-5 8.4 +19 ± 1 -55 ± 3 
Hb-TETA80-5 8.8 +23 ± 1 -89 ± 4 
Hb-TETA60-7 7.5 +14 ± 0.5 -28.9 ± 4.1 
Hb-TETA60-5 8.7 +22 ± 1 -68.04 ± 8.8 
Hb-NH4Cl400-5 7.3 +10 ± 0.5 -10 ± 0.9 
Hb- NH4Cl800-5  +10.8 ± 0.5 -14 ± 0.4 
Hb- NH4Cl1k-5  +11.6 ± 0.5 -16 ± 0.9 
Hb- NH4Cl1.5k-5  +15 ± 0.5 -17 ± 1.5 
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3.4.6 Circular dichroism studies:  
    In order to assess any distortions in secondary and tertiary structure of Hb in Hb-
TETA derivatives due to chemical modification, circular dichroism spectra of the 
samples were compared with that of the unmodified Hb. The UV-CD spectra are highly 
sensitive to the changes in protein secondary structure and they serve as excellent probes 
to examine protein structure.128 The UV CD spectra of Hb spectra has a strong peak 
maximum at 190 nm and double minima at 208 nm and 222 nm.129 The CD spectra of 
Hb-TETA derivatives overlapped with that of the unmodified Hb, reordered under same 
conditions (Figure 3.7). Thus, the secondary structure of Hb has largely been retained 
after chemical modification with TETA. Similarly, the CD spectra of Hb-TETA 
derivatives reordered in the presence of PAA, showed that the spectra nearly well 
overlapped with that of Hb, except for a minor distortion in the case of Hb-TETA80-
5/PAA ( Figure 3.8). Hence, the majority of the samples, retained their structure after 
chemical modification and binding to PAA. 
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Figure 3.7. Far UV CD spectra of unmodified Hb (black line), Hb-TETA40-7 
(Blue line), Hb-TETA40-5 (Red line) and Hb-TETA80-5 (Green line). All 
samples contained same amount of protein in PBS pH 6.4 buffer. Note that the 
peak positions and intensities of Hb did not change upon chemical modification. 
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Figure 3.8. Far UV CD spectra of unmodified Hb and Hb-TETA derivatives in 
the absence (black line) and in the presence (Blue dash line) of PAA. All 
samples contained same amount of protein and PAA that was used for ITC 
measurements and were in PBS pH 6.4 buffer. CD spectra imply that there are 
no major distortions in protein secondary structure when bound to PAA. 
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          We also examined the structure by recording the Soret CD, which is a sensitive 
measure of the asymmetry of the heme environment. The Soret CD spectra of the Hb-
derivatives and their complexes with PAA (Figure 3.9). Since peak positions and 
intensities are the same, the heme coordination environment is well preserved when the 
protein was modified or modified protein was bound to PAA. Encouraged by the fact 
that PAA did not distort the structure of Hb or Hb-TETA derivatives to a significant 
extent, only minor changes noted, we proceeded to examine the binding enthalpies. 
 
 
 
 
 
 
 
 
 
 
 
  120 
             
              
 
Figure 3.9. Soret CD spectra of unmodified Hb and Hb-TETA derivatives in 
the absence (black line) and in the presence (Blue dash line) of PAA. All 
samples contained same amount of protein and PAA that was used for ITC 
measurements and were in PBS pH 6.4 buffer.  
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3.4.7 Model-independent binding enthalpies:  
         As mentioned earlier, the estimation of the binding enthalpies from ITC curves 
using the model dependent method could introduce potential errors due to the tacit 
assumptions made in the model.  Hence, we chose to measure the binding enthalpies of 
the Hb-derivatives with PAA, directly by the model independent method.  The protein 
and polymer concentrations have been chosen such that each addition of the protein 
solution resulted in complete binding to PAA.  The heat released or absorbed, under 
these conditions, was corrected for dilution, and the corresponding binding enthalpies 
evaluated. 
The calorimetric curves representing the addition of Hb-TETA80-5 to PAA (black), Hb-
TETA80-5 dilution  (blue) and PAA dilution (red), in PBS at pH 6.4, are shown in 
Figure 3.10 A.  The area under the peak for each injection (q) was used to calculate the 
binding enthalpy (ΔHHb/PAA) and appropriate corrections have been made for the dilution 
enthalpies of the polymer (ΔHPAAdil) and the protein (ΔHHbdil), using equation 2.  The 
resulting, corrected binding enthalpies per mol of Hb-TETA80-5 bound to PAA (Figure 
3.10 B) was extracted to be -89+4 kcal/mol (Table 3.4).    
 
ΔHInteraction  = ΔHHb/PAA - (ΔHPAAdil+ ΔHHbdil) ----------------------------------- (2) 
 
 
 
 
 
  122 
A    
B  
Figure 3.10. A. Change in power due to the addition of Hb-TETA80-5 (60 µM) 
to PAA (9 µM, polymer)  (black curve), the dilution of Hb-TETA80-5 (60 µM)   
(blue curve), and dilution of PAA (9 µM)   (red curve). B. Change in power due 
to the binding of Hb-TETA80-5 to PAA, after correcting for the dilutions of Hb-
TETA80-5 and PAA (PBS, pH 6.4, 25 ˚C).  These peaks were integrated to 
extract the corresponding ∆H values. 
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      The binding enthalpies of Hb and all Hb-TETA derivatives were measured by this 
method, at pH 6.4, and their binding to PAA has been strongly exothermic. The binding 
enthalpies, measured under the same conditions of ionic strength, pH and temperature, 
varied from -45 to -89 kcal/mol (Table 3.4). The binding enthalpy of Hb measured by 
the titration method was -7.4+0.2 kcal/mol, which is in good agreement with the value 
obtained from direct method (-8.0+0.2 kcal/mol, Table 4.4).  None of these 
protein/polymer complexes precipitated under these conditions, and proper corrections 
were done for dilution to obtain heat release due to protein interactions with PAA. 
         The Hb-TETA/PAA binding enthalpies are analyzed with respect to the protein 
charge, and plot of the binding enthalpies vs their charge was shown in Figure 3.11 
(blue dots). These showed a strong trend, and linear fit to the data had a slope of – 3.8 
kcal/mol per unit charge.  The steep, favorable, dependence of ∆H on protein charge, 
was observed with the TETA derivatives, and TETA modification substantially 
increased the binding exothermicity. 
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Figure 3.11. Binding enthalpies of Hb-TETA (blue dots) and Hb-Ammonia 
derivatives (black dots) (60 µM) to PAA (9 µM) as a function of their charge.  
Slopes of the linear fits to the TETA and ammonia derivatives are – 3.8 and -1.0 
kcal/mol per unit charge, respectively (PBS, pH 6.4, 25 ˚C). 
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3.4.8 Binding enthalpies of the Hb-Ammonia derivatives:  
       Several factors contribute to the binding enthalpies measured above, and to separate 
the enthalpy contributions from protein charge vs the specific interactions of TETA side 
chains, we measured the binding enthalpies of similarly charged Hb-derivatives 
prepared from the chemical modification with ammonium chloride, rather than TETA.  
The TETA side chains may specific contributions to the binding enthalpies, and these 
have been evaluated using the Hb-Ammonia charge ladder. 
 The binding enthalpies of the members of the Hb-Ammonia charge ladder were 
obtained, under identical conditions of pH, ionic strength, and temperature as those of 
the TETA derivatives.   Concentrations and the extent of modification have been 
adjusted such that all protein/PAA complexes were completely soluble and there has 
been no precipitation.  The binding of this charge ladder was also exothermic, but the 
exothermicity increased much more slowly from -10 to -17 kcal/mol, while their charge 
varied over a range of +10 to +15 (Table 3.4 ), at the same pH, buffer and ionic strength.    
A plot of the binding enthalpies of the ammonia derivatives vs charge (black dots, 
Figure 3.11) was also linear but had a slope of -1 kcal/mol per unit charge.  Magnitude 
of this slope is ~4 times smaller than that noted for the TETA derivatives. Therefore, it 
is clear that appending TETA to Hb has a strong synergistic effect to the binding 
enthalpies. 
 
3.4.9 Activities of polymer-protein complexes:  
    The anomalous binding enthalpies of Hb-TETA derivatives could be due to extensive 
unwinding of the protein, before or after interaction with the oppositely charged PAA 
molecules.  Therefore, we set out to assess the biological activities of the Hb-derivatives 
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and their complexes with PAA.  Hb does not function as an enzyme in nature, but its 
peroxidase-like activity is well documented.130 Therefore, the peroxidase-like activities 
have been determined, and compared, under the same conditions of pH, ionic strength, 
buffer and temperature.  
 
            The catalytic activities of Hb-TETA samples and Hb-TETA/PAA physical 
mixtures were determined using o-methoxyphenol as the substrate and H2O2 as the 
oxidant.  Absorbance change at 470 nm due to product formation was monitored, as a 
function of time (Figure 3.12).   All samples indicated a high degree of activity, and 
chemical modification did not inhibit their activities to a significant extent.  Specific 
activities were determined from the initial rates of the activity curves, and these ranged 
from 0.74 to 0.94 per µM per s ( Table 3.5). 
 
             The Hb-TETA derivatives also retained their activities after complexation with 
PAA, and these have been compared with those obtained in the absence of the polymer 
(Figure 3.13).  The specific activities of the Hb-TETA/PAA complexes varied from 118 
to 90% of that of Hb, and some of them improved slightly when compared to that of Hb.  
Therefore, neither chemical modification nor complexation with PAA had significant 
effect on the peroxidase-like activities of the Hb-TETA charge ladder.   
 The excess enthalpy change observed for Hb-TETA derivatives is not due to the 
distortion or denaturation, or precipitation of the protein-polymer complexes.  It must be 
originating from intrinsic interactions between the modified protein and the polymer. 
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Figure 3.12. Comparison of activities of modified and unmodified Hb (1 µM) in 
the presence and absence of PAA (0.15 µM) in PBS buffer pH 6.4 at room 
temperature 
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Table 3.5 Specific activities of Hb-TETA derivatives and their complexes with PAA 
(µM.s x 103) 
 
Sample Activities 
(proteins) 
% 
Activity 
Activities 
(protein/PAA 
complexes) 
% Activity 
Retention 
Hb 0.93 ± 0.06 100 1.08 ± 0.06 116 ± 6.4 
Hb-TETA40-7 0.94 ± 0.028 100 ± 3 1.1 ± 0.02 118 ± 2.1 
Hb-TETA40-5 0.89 ± 0.04 96 ± 4.3 0.91 ± 0.04 0.98 ± 4.3 
Hb-TETA80-5 0.74 ± 0.01 80 ± 1.1 0.87 ± 0.02 0.93 ± 2.1 
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Figure 3.13. Relative activities of Hb-derivatives (1 µM) in the presence or 
absence of PAA (0.15 µM), with respect to that of Hb, in PBS, pH 6.4, at 25 ˚C. 
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3.5 Discussion 
 Unlike the interaction of a small, charged ligand with polymers, the interaction 
of proteins with polymers is more complicated.  The presence of twenty different amino 
acid building blocks of the protein introduce various chemical and physical properties to 
the protein, and these make it a complex moiety to study. For example, the use of 
different proteins with specific charges to study the charge dependency on protein-
polymer complex formation, at a particular pH, is complicated, since each protein has a 
unique way of folding which results in variability of the hydrophobic and charged 
patches on the protein surface.  
              Many factors could contribute to the formation of soluble protein/polymer 
complexes,109,110,131 and electrostatic interactions have been implicated to play a major 
role.117 Contributions of interactions other than electrostatic interactions is much less 
understood.132 Hydrophobic interactions were shown to play a major role in the binding 
of bovine serum albumin (BSA) to hydrophobically modified PAA.133 Gelation and 
precipitation of proteins by polymers are suggested to be due to hydrophobic 
interactions between proteins and polymers.134,110,135 H-bonding and electrostatic 
interactions, hydration or dehydration or ion release or ion uptake were implicated in 
protein binding to inorganic polymeric materials.113,114 
               As a model system, here, we first examined the binding of Hb with a water-
soluble weak polyelectrolyte, PAA (MW 450,000).  Binding constant from data for 
Hb/PAA soluble complex formation is 3.2±0.7x 105 M-1, which is in fair agreement with 
the binding constant obtained from SPR (7.1 x 105 M-1).  This value is similar to the 
binding constant observed with calf thymus DNA, anionic biopolymer, of 4.9 x105 M-1, 
in Tris buffer at pH 7.0.136 On the other hand, the binding constant of Hb with α-Zr(IV) 
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phosphate, anionic rigid, inorganic polymer, was reported to be 5.4x106 M-1, an order of 
magnitude higher than observed with PAA.137 Note that this solid is strongly negatively 
charged, one negative charge per 25 Å2, and higher binding consistent with the idea that 
electrostatic interactions contribute substantially for Hb binding to its partners.  In 
support of this notion, positively charged lysozyme was reported to bind to PAA with 
comparable affinities.105 
                      From the observed stoichiometric ratio of 14:1, we propose that each Hb 
molecule occupies nearly 120 nm along the PAA chain, spanning 400 monomeric units, 
and that PAA wraps around the protein (beads-on-a-string model) due to favorable 
interactions with surface groups of the protein.  The positively charged patches on Hb 
could interact favorably with the negatively charged carboxyl groups of PAA. 
 
 
 
 
 
Scheme 3.3. Schematic representation of soluble intrapolymer complex 
formation between Hb and PAA. 
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            According to the ITC data, the binding of Hb to PAA is exothermic (-7.4 
kcal/mol, obtained at pH 7.4 in PBS) and the enthalpy change could be due to patches of 
positive charges on its surface despite its weak negative charge at pH 7.4 (pI ~7). When 
the pH was dropped to 6.4, the ∆H decreased from -7.4+0.2 to -8+0.4 kcal/mol, and this 
is consistent with the fact that Hb is slightly positively charged at pH 6.4 and greater 
electrostatic interactions contribute at lower pH.   The binding of Hb to calf thymus 
DNA was weakly endothermic (∆H=3.1 kcal/mol) at pH 7 in Tris buffer.136 Along these 
lines, the binding of Hb to α-Zr(IV) phosphate was found to be strongly exothermic -24 
kcal/mol, at pH 7.2, in phosphate buffer114 due to the high charge density of this solid, as 
discussed earlier. The binding enthalpy for the interaction of strongly positively charged 
lysozyme to PAA (MW, 240,000) was reported to be -10 kcal/mol, at pH 5.5, and also 
supports the role of electrostatic interactions in its binding to PAA.105 Thus, binding 
enthalpies or entropies differed in terms of the type of host material, pH, molecular 
weight of PAA and the buffer used for the studies.  Therefore, we decided to chemically 
modify the net charge on Hb, and examine the trends in the binding parameters with 
PAA as a model polymer, under a consistent set of conditions to gain insight into the 
binding.  
To evaluate the role of electrostatic interactions in these, at constant pH and ionic 
strength, without using different proteins or different host materials, we have prepared a 
number of Hb-derivatives of two separate charge ladders, TETA and ammonia. Note 
that modification of Hb with ammonium chloride would convert the glutamic or aspartic 
COOH groups to the corresponding CO-NH2 groups, while reaction with TETA would 
produce CO-TETA groups on the protein.  The basic nitrogens of TETA can be 
potentially protonated to produce additional positive charges.  Therefore, these 
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differences are to be kept in mind in the interpretation of the observed data.  At a given 
pH, the net charge on the protein is systematically varied to study its contribution to the 
binding interactions. 
Hb modification with TETA resulted in the charge ladder (Figure 3.3), which indicated   
progressive decrease of binding enthalpies from -8+0.2 kcal/mol for Hb to -89+4 
kcal/mol for Hb-TETA80-5 (Figure 3.11).  The slope of the linear fit to these data 
indicated enthalpy decreases of -3.8 kcal/mol per unit charge.  In contrast, the enthalpy 
decrease noted with the Hb-Ammonia ladder has been from -8+0.2 for Hb to -17+1.5 
kcal/mol for Hb-Ammonia1.5k-5 with a slope of -1.0 kcal/mol per unit charge.  The 
latter value is in good agreement with reported values for coulombic interactions, ΔHEle 
105 but it is much smaller than noted for Hb-TETA charge ladder.  
        This discrepancy between the two sets of data could be attributed to additional 
contributions from the TETA ligand, such as hydrogen bonding with the amino groups 
and hydrophobic interactions from the ethyl segments of TETA (Scheme 3.4). To test 
this hypothesis, we have examined TETA binding to PAA by ITC, under identical 
conditions of pH, ionic strength and temperature.  The binding of TETA to PAA was 
also exothermic with a ∆H of -2 kcal/mol per TETA.  The estimated charge on TETA at 
pH 6.4 is +2, and hence, the ∆H per unit charge is -1.0 kcal/mol of charge on TETA, 
which is in good agreement with the ∆H value noted for the Hb-Ammonia derivatives 
but much lower than that of Hb-TETA derivatives (-3.8 kcal/mol charge). 
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Scheme 3.4:  Proposed hydrogen bond formation between TETA linked to Hb 
and PAA.  
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             The dependence of binding enthalpies on protein charge observed here, is in 
good agreement with previous related work. Several key studies examined the 
interactions between oppositely charged peptides and polyelectrolyte microgels.138,139,140 
The strength of peptide-microgel interaction depended on the charge contrast between 
the peptide and the microgel.  The binding and release kinetics of the peptide with the 
microgel depended directly on the net charge on the peptide as well as the microgel, and 
these are consistent with the current observations, despite the fact that two distinct 
approaches are being used. These previous data are in support of our current findings, in 
that the binding enthalpies gradually increase with increasing charge contrast, just as the 
on-off rates of the peptides increased with charge contrast.  Unfortunately, these earlier 
studies did not quantify the relationship between the charge and binding enthalpies but 
related to the kinetics of association and release.  Strong role of electrostatic 
contributions are clearly supported by thee studies and current data are consistent with 
earlier reports. 
                 The difference between the binding enthalpies of the Hb-TETA and Hb-
Ammonia derivatives (-3.8 vs -1 kcal/mol of charge) still needs to be explained. 
Increased substitution with TETA chains have greater chance to produce clusters of 
multiple charges by the close proximity of two or more TETA ligands on the protein 
surface.  When these charges are separated by distances shorter than the Debye length (8 
Å) at the ionic strength (150 mM ionic strength), they could function as a multivalent 
point charge, which can enhance the electrostatic interactions. This explanation is along 
the lines of previously reported peptide-microgel interactions where enhanced 
interactions due to charge-localization of charge clusters was invoked.140 Clustering of 
charges along the TETA chain could function as a multivalent point charge, as opposed 
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to uniform distribution on the protein surface, and charges farther than Debye length 
would not substantially contribute to binding.  
                To make sure that observed excess enthalpy change (synergy) is not due to the 
unwinding of protein structure by PAA and subsequent enhanced interaction of the 
denatured protein with PAA, we proceeded to examine the secondary structures of the 
protein/PAA complexes.  Unwinding of Hb by PAA will substantially decrease Hb 
secondary structure.  However, we find that the CD spectra of the Hb/PAA complexes 
and their enzymatic activities are similar to Hb without PAA (Figure 3.8). Therefore, 
these structural changes are only minor, if any, and cannot account for the enhanced 
binding enthalpies of Hb-TETA derivatives.  
                   If there are protein structure distortions that are not readily visible in the CD 
studies, they might influence its peroxidase-like activity.  The peroxidase-like activities 
of the Hb-derivatives and their complexes with PAA are reasonably comparable to that 
of Hb (Figure 3.13).  Interestingly, there have been small improvements in activities in 
specific cases, on binding to PAA.  Therefore, it is unlikely that the excess binding 
enthalpies can be accounted for by the unwinding of the protein and its interaction with 
PAA.   Neither chemical modification nor binding to PAA resulted in substantial loss of 
activity.  Therefore, PAA-induced conformational changes in hemoglobin are minimal 
and cannot account for enhanced binding enthalpies. PAA conformational changes 
accompanying Hb binding, if any, are expected to be very small as the polymer adopts 
the conformations of a random coil.141 
                 One other issue is that the conversion of the COOH groups on the protein 
surface to CO-NH2, neutralizes the local negative charge and could alter the Hb/PAA 
contact points but may not necessarily involve the newly introduced CO-NH2 groups in 
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the interaction, since these are polar but not charged.  In contrast, TETA chains attached 
to Hb would favorably interact directly with COOH groups of PAA (Scheme 3.4) and 
this interaction could promote additional contacts with functional groups on the protein 
surface.  These new interactions could potentially alter the points of contact between Hb 
and PAA.  In simple terms, chemical modification alters the overall charge but it might 
also alter the points of contact between the protein and the polymer, and charge 
localization or clustering of TETA charges could enhance the interactions further.  
These aspects depend on the type and nature of chemical modification that has been 
carried out.  Thus, controlled chemical modification provided a powerful new tool to 
alter binding enthalpies in a quantitative manner, without adversely affecting the 
biological activity, in a predictable, linear manner, in the charge range examined here.  
This powerful approach could be expanded to other systems, and it might be useful to 
fine-tune the protein-polymer interactions in a systematic manner via benign, controlled 
chemical modification of protein side chains. 
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3.6 Conclusions 
 The Hb and PAA interaction is weakly exothermic at pH 7 and the binding is 
mostly enthalpy driven but entropically favorable. Approximately, 14 Hb molecules 
associate with one PAA polymer chain, on an average, or occupy about 120 nm along 
the polymer backbone.  One reason to form such discrete structures could be due to the 
extremely low concentrations of the polymer used here (0.7 µM).  Regardless of the 
binding motif, discrete Hb-PAA complexes are produced, which are completely water-
soluble and did not form macrogels or insoluble precipitates. 
 Carefully controlled chemical functionalization and consequent introduction of 
charge groups on Hb is a novel strategy to manipulate Hb interaction with PAA.   
Binding exothermicity has been substantially improved by chemical modification of the 
COOH groups of Hb with TETA, at a rate of -3.8 kcal/mol per unit charge.  This 
provided a powerful approach to fine-tune the binding enthalpies, at least in this charge 
and concentration regions.  In comparison, the binding enthalpies of the Hb-Ammonia 
charge ladder increased at a low rate of -1.0 kcal/mol per unit charge.  We speculate that 
the excess exothermicity associated with the TETA derivatives as compared to that of 
the Hb-Ammonia derivatives can be due to changes in the contact points between the 
protein and the polymer, and possible localization of charge on protein surface with 
increased modification.  The binding enthalpies of the Ammonia or the TETA 
derivatives can be predicted within the region examined here. 
  While chemical modification appeared to be a simple approach to factor out the 
electrostatic contributions to the protein-polymer interactions, it could potentially alter 
the protein-polymer contact points and hence, alter the strength/nature of these 
interactions further.  Nevertheless, this synergy could be useful in tuning the binding 
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enthalpy in a systematic manner and the enthalpy change can be controlled by 
controlling the type and extent of modification used, under defined conditions. This type 
of ability to manipulate the molecular nature of protein/polymer interactions could be 
useful in designing novel protein/polymer hybrid materials for biomaterial and 
biotechnological applications. 
           
 
Reprinted (adapted) with permission from Thilakarathne,V.K. ; Briand, V.A.; Kasi, 
R.M; Kumar, C.V. Tuning Hemoglobin-Poly(acrylic acid) interaction by Controlled 
Chemical Modification with Triethylenetetramine. J.Phys.Chem.B. 2012, 116, 12783-
12792. 
             Copyright (2012) American Chemical Society. 
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Chapter 4 : Chemically Modified Protein/DNA Interaction Towards 
Fabrication of Bio-Solar Cells 
 
4.1 Abstract  
 
Solar energy is abundant, renewable and inexhaustible which would last over geologic 
time scales. However, successful design of an artificial light-harvesting complex is 
required for an efficient collection, capture and conversion of solar energy over a wide 
range of wavelength.  We report here the successful construction of light gathering 
complexes consisting of multiple donor-acceptor dyes bound to protein-DNA 
complexes, in a self assembled manner.  Our system consists of three distinct donors and 
an acceptor which absorb the wavelength range of 300-600 nm.  Upon excitation of any 
one of the donor dyes, rapid energy transfer to the acceptor is noted which is followed 
by intense emission from the acceptor.  Excitation spectra clearly show that each of the 
three donors transfer their excited state energy to the single acceptor. Steady state 
fluorescence study reveals an efficient step-wise energy transfer between the four 
chromophores used. These artificial light gathering complexes are unique, the first of 
their kind and facilitate our efforts toward the construction of bio-solar cells from 
proteins and nucleic acids. 
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4.2 Introduction 
 
                       Higher depletion rate and adverse environmental impact of carbon-based 
fuels have raised the issue of development of long term, sustainable and green energy 
source to relinquish world’s energy crisis142. Solar energy is abundant, sustainable and a 
renewable source, which has the highest potential to replace carbon-based fuels143. 
Major obstacle standing in the way of efficient solar energy conversion is the low energy 
density and broad spectral distribution of the solar source, which requires efficient 
energy capture over a wide range of wavelength. Photosynthetic systems in plants 
capture maximum amount of solar energy with the help of a set of pigments bound to 
well-organized non-covalent self-assembled protein complexes144,145. Inspired by this 
concept we designed a protein and DNA based artificial antenna complex to efficiently 
capture maximum amount of solar energy. Fabrication of robust artificial antenna 
complexes with higher energy transfer efficiencies that mimics what plant does is a 
challenging process. Several successful artificial antenna complexes were reported that 
used tobacco mosaic virus coat protein146, dendrimers147, DNA bundles148 and DNA 
origami structures149 as scaffolds for chromophores. Many of these methods involve 
tedious conjugation reactions, several purification steps and lack of solid-state 
applications. Our work stands out among reported strategies since we fabricate far more 
convenient, yet robust, self-assembled muti-choromophore system in solid state using 
biopolymers.   
              In order to capture solar energy, carefully selected donors and acceptors (four 
chromophores) were arranged in self-assembled DNA-protein hybrid materials. The 
provided close proximity of the scaffold for donor and acceptor chromophores promotes 
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Föster resonance energy transfer (FRET) process. Bovine serum albumin (BSA) is an 
excellent host for binding numerous chromophores150,151, and in a similar manner; the 
double stranded DNA also can provide an opportunity to accommodate a number of 
donor and/or acceptor chromophores152,153. However BSA has no affinity for DNA at pH 
7 due to charge repulsion and this problem was overcome in our laboratory by chemical 
modification of BSA using polyamines (Scheme 4.1). 
          Tightly bound DNA/cBSA complex was served as the scaffold to accommodate 
donors and acceptor chromophores. Our hypothesis is that reducing the Föster radius 
between donors and acceptors by non covalently assemble them in DNA/cBSA scaffold; 
energy transfer efficiency can be improved (Scheme 4.2). Previously published data 
from our group have shown that Donor/DNA/ cBSA/Acceptor quaternary system has 
increased the energy transfer efficiency compared to two dyes alone154. 
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Scheme 4.1: Activation of carboxylic groups on the surface of BSA using water 
soluble carbodiimide followed by amidation using triethyleneteramine to 
produce the corresponding catinized BSA (cBSA). 
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Scheme 4.2: Artificial antenna complex constrcuted from donors, acceptors , 
modified BSA (cBSA) and DNA.  
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  Here we reported the design and construction of biomacromolecule based self-
assembled artificial antenna complex that contains four chromophores, DNA and 
proteins. A unidirectional step-wise energy transfer cascade from initial donor 
chromohopre to primary and secondary acceptors and at the end to the ultimate acceptor 
was demonstrated using steady state fluorescence spectra analysis. 
 
4.3 Experimental details 
 
4.3.1 Materials 
Bovine serum albumin was purchased from  and fish sperm DNA sodium salt was 
purchased Amresco (Ohio) . Dyes used for the experiment, bisBenzimide H 33258 
(Hoechst) and Fluorescein were purchased from sigma.   Coumarin C540A was  
purchased from Exciton chemical CO.Inc (Ohio) and  Rhodamine was from Eastam 
Kodak company NY. Glass cover slips with dimensions 22mmx22mm were purchased 
from Fisher Scientifics.  
 
4.3.2 Synthesis of cationic bovine serum albumin (cBSA) 
        Aspartic and glutamic acid residues of BSA were modified by activating them with 
carbodiimide and by reaction with triethlenetetramine (TETA) , by adopting reported 
methods. BSA ( 1g) was dissolved in deionized water and stirred with 0.5 M TETA (pH 
adjusted to 5) for half an hour followed by addition of 50 mg of EDC. The reaction 
mixture was stirred for additional 4 hrs at room temperature and unreacted EDC, TETA 
and byproducts were removed by dialysis against 10 mM phosphate buffer at pH 7.2 . 
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TETA attached BSA ( Cationized BSA or cBSA) was then concentrated using amicon 
tubes ( 20,000 MW)  
 
4.3.3 Agarose gel electrophoresis 
       Agarose gel electrophoresis was used to determine the extent of chemical 
modification on TETA attched BSA.  Agarose gel electrophoresis was performed using 
horizontal gel electrophoresis apparatus (Gibco model 200, Life Technologies Inc, MD) 
and agarose (0.5 % w/w) in tris acetate (40 mM) buffer at pH 7. Modified and 
unmodified BSA samples were loaded with 50 % loading buffer (50% v/v glycerol and 
0.01% w/w bromophenol blue). Samples were spotted into wells placed in the middle of 
the gel , so that the protein could migrate towards the negative or the positive electrode, 
based on net charge. A potential of 100 V was applied for appropriate duration. Gel was 
stained over night with 10% v/v acetic acid and 0.02% w/w coomassie blue , followed 
by destaining in 10% v/v acetic acid overnight. 
 
4.3.4 Fabrication of thin films using drop casting method. 
 Thin film of self-assembled cBSA/DNA/dye complex was constructed by preparing two 
separate solution of cBSA/Rhodamine/Fluorescein/C540A and DNA/Heochst solution 
and finally mixed both solutions together allowing dyes and macromolecules to arrange 
in self-assembled manner. Rhodamine in DI (40 µM) was added to cBSA solution (300 
µM) in 10 mM phosphate buffer pH 7 and mixed well. After that Fluorescein (100 µM) 
in DI and C540A (125 µM) in DMF were added to the cBSA solution respectively. 
DMF content in the final complex should be less than 1% v/v. DNA/dye solution was 
prepared by adding  Hoechst (100 µM) in DI   to a DNA solution (800 µM) in 10 mM 
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phosphate buffer pH 7.  cBSA/dye solution and DNA/dye solution that were prepared 
separately was then combined together and mixed well to arrange in a self-assembled 
cBSA/DNA/chromophores complex. Concentrations of dyes, cBSA and DNA 
mentioned above are the final concentrations of each in the self-assembled complex. 
Chromophore content of the final complex was kept below 5 % v/v. Once the self 
assembled complex was formed in the solution,  500 µl of the solution was taken and 
covered the surface of the 22mmx22mm glass coverslip and allowed to air dry 
overnight. 
 
4.3.5 Absorption and steady state fluorescence measurements 
Absorption spectra of each film on glass cover slip were reordered using HP 8453 diode 
array spectrophotometer. Steady state fluorescence spectra were collected using home-
build fluorescence spectrophotometer using SLM-Aminco optics. The instrument is 
routinely calibrated prior to each experiment. Front phase accessory was used to collect 
emission and excitation spectra of thin films. During absorbance and steady state 
fluorescence experiments, glass cover slip was aligned in both instruments in such a way 
that the same area is exposed to both absorbance light beam and to the excitation beam 
in fluorescence.  
 
 
4.3.6 High temperature stability 
Protein/DNA/Dye films were incubated at 80 0C  and absorbance and fluorescence 
spectra were collected after  certain time intervals. Films were allowed to cool 2- 3 hours 
prior to take measurements. 
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4.4 Results and Discussion 
4.4.1 Chemical modification of BSA 
             Bovine serum albumin used in this study has a pI of 5 and hence negatively 
charged at pH 7.2. At this pH, because of the charge repulsion BSA does not bind to 
DNA. Aspartic and glutamic acid residues on the surface of BSA were conjugated with 
triethylenetetraamine (TETA) using EDC mediated coupling reaction. Charge reversal 
of BSA was monitored using agarose gel electrophoresis, where protein was subjected to 
an electric field. Since the very low percentage of agarose was used (0.5%) distance 
migration in the native gel is proportional to the charge of the protein (Figure 4.1) and 
the effect of protein size is minimal. For example at pH 7, since unmodified BSA is 
negative charge it migrated towards positive electrode (Figure 4.1 lane 1 ). After 
chemically modified with TETA the protein migrated towards negative electrode which 
signifies charge reversal (Figure 4.1 lane 2). Hence chemically modified BSA would be 
denoted further as cationic BSA or cBSA. 
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Figure 4.1: Agarose gel of unmodified BSA (lane 1) and BSA modified with 
TETA (cBSA)  (lanes 2, 40 mM Tris acetate, gel run at pH 6) and samples were 
loaded into wells at the middle of the gel (dotted line). 
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4.4.2 Selection of chromophores 
                   According to Föster energy transfer theory, efficient energy transfer between 
donor/acceptor pair, was observed upon fulfillment of following requirements155. 
1. Significant overlap between the donor emission and acceptor absorption in the 
frequency domain 
2. Coulombic interaction between oscillation dipole moments of acceptor and excited 
donor 
3. Separation of donor and acceptor (Föster radius) 
 
        Four chromophores that satisfy the required spectral overlap were chosen from 
commercially available organic chromophores. Hoechst  (λmax,Abs=340nm, 
λmax,Em=440nm) is the  donor in the system that binds specifically to DNA156. Coumarin 
540A (λmax,Abs=420nm, λmax,Em=520nm) and Fluorescein (λmax,Abs=490nm, 
λmax,Em=510nm) are primary and secondary acceptors respectively while Rhodamine B 
(λmax,Abs=550nm, λmax,Em=575nm) is the ultimate acceptor.  Rhodamine, Fluorescein and 
C540A are well known for binding to BSA150,157,158.  Once the 
DNA/cBSA/Donors/Acceptors complex was formed in a self assembled manner close 
proximity of chromophores decrease the Föster radius and provided the ground to 
improve energy transfer efficiency. The self-assembled complex was then used to 
fabricate thin films on glass surface using drop casting method. Bovine serum albumin 
in the complex acts as a glue that stick the complex on to the glass surface.  These thin 
films were used to perform absorbance and steady state experiments. 
    Selected chromophores capture solar energy from 300- 600 nm spectra region. 
According to the absorption and emission spectra, significant overlap was notable 
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between emission spectra of Hoechst (Figure 4.2 blue dash line ) and absorbance 
spectra of C540A( Figure 4.2 green solid line). Similarly higher overlap integral was 
observed between C540A/Fluorescein pair  and Fluorescein/Rhodamine chromophores 
pair (Figure 4.2). Spectral overlap was minimal between Hoechst/Fluorescein and 
C540A/Rhodamine dye pairs. These spectral features allow achieving unidirectional, 
stepwise energy transfer cascade between four chromophores bound to cBSA and DNA.  
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Figure 4.2 : Overlap of absorbance  and emission  spectra of the four 
chromophores used to make the artificial antenna complex. Abbreviations of 
dyes are ; H for Hoechst (Blue), C for C540A (Green), F for Fluorescein 
(yellow) and  R for Rhodamine (red). 
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4.4.3 Steady state fluorescence study 
The FRET between  four-dye system was investigated using steady state fluorescence 
spectroscopy. Antenna complex was excited at the absorbance maxima of the initial 
donor Hoechst (λ=350 nm) where the ultimate acceptor, Rhodamine does not absorb 
significantly. The fluorescence spectra of four dyes with DNA and cBSA (Figure 4.3 A 
black line) shows a six fold increase in Rhodamine emission compared to Rhodamine 
only with DNA and cBSA (Figure 4.3 A  blue dash line).  More interestingly when 
intermediate primary or secondary acceptors are removed from the system, Rhodamine 
emission decreases and the corresponding donor quenching is also decreases. For 
example in the absence of C540A Hoechst emission was not quenched (Figure 4.3 B 
red line) and in the absence of Fluorescein C540 emission was not quenched (Figure 4.3 
B green line). 
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A  
B       
Figure 4.3 : Emission spectra of the self-assembled system showing the 
contribution of each chromophore to the energy transfer cascade. (Abbreviations 
of dyes are ; H for Hoechst, C for C540A, F for Fluorescein and  R for 
Rhodamine). A) Note that the Hoechst emission was quenched and Rhodamine 
emission was increased in the presence of primary and secondary acceptors, 
C540 and Fluorescein respectively. B) Clear evidence of step-wise energy 
transfer cascade has shown since elimination of each intermediate results in 
decrease in Rhodamine emission and increase in corresponding donor emission. 
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        In solid phase, molecular diffusion between donor molecules and acceptor 
molecules is prevented as they are fixed  in rigid positions relative to each other. In such 
situations Perrin formulation is used to determine the quenching radius between donors 
and acceptors in a quenching spheres155. When donor chromophore and acceptor 
chromophore positioned within the quenching sphere, the acceptor molecule quenches 
the excited donor molecule emission. Any excited donor molecules resides out side the 
quenching sphere cannot be quenched by the acceptor molecule (Scheme 4.3 ). Hence 
quenching radius derived from Perrin formulation in solid state is comparable to the 
Föster radius discusses in Föster theory.  
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Scheme 4.3 Depiction of quenching sphere described in Perrin model that used 
to explain quenching phenomenon in solid-state systems.  
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         Quenching radii of consecutive dye pair were extracted from the following Perrin 
equation (01)155. 
 
              ln Φ0/Φ  = VN[Q] ------------------------------------- Equation (01) 
             
Where Φ0 and Φ are the quantum yield for donor emission in the absence and presence 
of acceptor, V is the volume of the quenching sphere; N is the Avogadro’s number and 
[Q] is the concentration of the acceptor. 
         For example in order to determine the quenching radius between Fluorescein and 
Rhodamine , Rhodamine concentration was changed and emission spectra were 
collected ( Figure 4.4 A). Note that the plot of ln ln Φ0/Φ  vs quencher concentration is 
linear which states that quenching phenomenon behaves according to Perrin model 
(Figure 4.4 B & C). 
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A                                            B                                        C                                 
Figure 4.4. A) Increase in quenching of Fluorescein emission by increasing 
Rhodamine concentration. B) Plot of ln Φ0/Φ  vs quencher (Rhodamine) 
concentration. Note that the plot is non linear. C) Plot of  ln Φ0/Φ  vs quencher 
(Rhodamine) concentration. Linear plot implies the quenching follows Perrin 
model. 
 
 
 
 
 
  Similarly quenching radius between Fluorescein and C540 was determined by 
changing Fluorescein concentration and radius between C540 and Hoechst was 
determined by changing C540 concentration ( Figure 4.5). 
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A    B  
C  D  
Figure 4.5  A) C540 emission was decreased concomitantly by increasing 
quencher (Fluorescein) concentration. B) Plot of  ln Φ0/Φ  vs quencher 
(Fluorescein) concentration. Quenching radius between C540 and Fluorescein 
was extracted from this Perrin plot.  C). Decrease of emission spectra of Hoechst 
due to the increase in C540 which as the immediate acceptor for Hoechst 
emission according spectra overlaps. D) Plot of  ln Φ0/Φ  vs quencher (C540) 
concentration. Quenching radius between Hoechst and C540 was extracted from 
this Perrin plot. 
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                Quenching radii between each chromophore pair, calculated from Perrin 
model were tabulated in Table 4.1. Those experimentally calculated radii are 
comparable to the known Föster radii between Fluorescein/Rhodamine pair (55 Å)159 
and Coumarin/Fluorescein pair (50 Å)160. 
 
Table 4.1 Quenching radii; extracted from Perrin plots. 
 
Chromophore pairs Quenching radius (Å) 
Rhodamine - Fluorescein 57 .5 ± 1 
Fluorescein – C540 44.6 ± 1.6 
C540 - Hoechst 60.37 ± 2 
 
                Static quenching was further confirmed by the excitation spectra. Excitation 
spectra were collected by monitoring the emission at 650 nm, where only Rhodamine 
has a significant emission, while all three donors have no emission. Intensity ratio of 
excitation peak maxima corresponding to Hoechst at 360 nm (primary donor absorption 
maxima) and Rhodamine at 561 nm (ultimate acceptor absorption maxima) is 
proportional to the energy transfer efficiency. The plot of I360/I561 as a function of each 
donor concentration showed that the energy transfer efficiency increases with donor 
concentration up to a certain concentration and then decreases (Figure 4.6). 
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A  B   
C  
Figure 4.6 Energy transfer efficiency as a function of donor concentrations 
monitored using excitation spectra. Emission was monitored at 650 nm.  A) 
Increase in concentration of Hoechst. B) Increase in concentration of C540A. C) 
Increase in concentration of Rhodamine. 
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The initial rapid increase in energy transfer is due to the accommodation of increasing 
number of donor molecules in the quenching sphere until it is saturated.  Above that 
concentration free donors would absorb the light but cannot contributes to the energy 
transfer process since they are out of the quenching sphere and decrease the overall 
transfer efficiency.  
       When the complex was excited at 350 nm (absorbance maxima of Hoechst), a 
drastic quenching of Hoechst emission at 450 nm , Coumarin emission at 550 nm and 
Fluorescein emission at 550 nm was observed . At the same time strong emission 
increase at 600 nm characteristics to Rhodamine was also observed (Figure 4.3). From 
this quenching data FRET efficiency was calculated using following equation (02)148.  
 
              E = 1-  IDA/ADA           ------------------------------- Equation (02) 
                          ID/ AD 
Where IDA and ID are integrated area of the donor emission with and without acceptor 
and ADA and AD are absorbances of donor with and without acceptor. Calculated energy 
transfer efficiencies (Table 4.2) further confirmed the step-wise energy transfer cascade, 
since the removal of one intermediate chromophore results in decrease in energy transfer 
efficiency. Overall 88% of ET efficiency was achieved by protein and DNA based multi 
chromophore antenna complex. 
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Table 4.2 : Energy transfer efficiency 
 
System Energy transfer efficiency 
From H to all the acceptors 88 % 
From H to F and R ( without C) 63 % 
From C to F and R 95 % 
From C to R ( without F) 48 % 
From F to R 72 % 
 
 
 
 
 
4.4.4 Morphology of  protein/DNA/Dye films 
        Morphology of the protein-DNA-Dye film was observed using scanning electron 
microscopy. The SEM image shows well-defined patterns of protein-DNA scaffold that 
stretched across the film in micrometer scale (Figure 4.7). All the defined structures 
have similar dimensions with few micrometer gaps in between (Figure 4.7). This 
remarkable discovery of scaffolding pattern of protein and DNA would be a great 
advantage when pursuing device fabrication.    
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Figure 4.7 SEM image of protein-DNA-Dye film. 
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4.4.5 Stability at higher temperatures 
         Major draw back associated with biomacromolecule based artificial antenna 
complex is the denaturation of proteins and nucleic acid at elevated temperatures. 
DNA/cBSA/Dye film on the glass surface was heated at 80 0C and emission spectra 
were collected as a function of time , after the film was cooled back to room 
temperature. Emission spectra shows that even after 21 days emission intensity decrease 
is minimum (Figure 4.8). The robust nature of the self-assembled antenna complex 
improved further the usefulness of the system in ultimate device fabrication. 
 
                       
Figure 4.8 Emission intensity at 586 nm ( emission of Rhodamine) vs time of 
incubation of DNA/cBSA/dye film and DNA/cBSA/Rhodamine film at 80 0C. 
Films were cooled down to room temperature for 2-3 hours before taking the 
collecting spectra.  
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4.5 Conclusion 
         Biomaterial based artificial antenna complex is not a strange thing compared to 
naturally occurring photosynthesis complex. In fact the design is entirely inspired by 
plant photosystems.  Very high concentrations of organic dyes in solutions cause drastic 
decrease in their quantum yields. If dyes arrange too close to each other, non-
fluorescence dimmers can form that act as excitation sinks and deplete excitation. 
Nevertheless in photosystem I and II chlorophyll concentration range from 0.5 to 0.25 
M161. Plant photosystems overcome this problem by organizing their chromophores in 
protein scaffolds, which enable to increase the local dye concentration at the same time 
optimize energy transfer efficiency162. Protein and DNA based scaffold reported here 
serve exactly the same purpose. Since all the components in the system self assembled 
according to their binding affinities, complex synthetic efforts are omitted although 
finely tuned order and distances couldn’t be obtained. In fact recent structural data and 
theoretical models explain that precise distances and symmetrical order of chromophores 
are not necessary for efficient energy transfer process. In a randomly arranged network 
of chromophores a highly optimal configuration can be found by statistical sampling163. 
The protein DNA based antenna complex can be further expand to harvest light over 
near IR range and will be useful for fabricate solar light harvesting complex that 
efficiently capture and convert solar energy to chemical energy.  
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